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ABSTRACT OF THE DISSERTATION
The Role of the Intestinal Microbiota in Inflammatory Bowel Disease
by
Seth Michael Bloom
Doctor of Philosophy in Biology and Biomedical Sciences
Molecular Microbiology and Microbial Pathogenesis
Washington University in St. Louis, 2012
Professor Thaddeus S. Stappenbeck, Chairperson

Inflammatory bowel disease (IBD) arises from complex interactions of genetic,
environmental, and microbial factors. The intestinal microbiota is crucial for IBD
induction and complex shifts in microbiota composition occur in IBD, but disease has not
been consistently associated with presence or absence of a specific microbe. It is thus
controversial whether fulfilling Koch’s postulates for individual bacterial species is
relevant to IBD and whether disease-associated alterations in microbial colonization are
predictive of underlying etiology. Resolving these controversies has been challenging due
to paucity of animal models with rapid disease onset, experimental reliance on
gnotobiotic animals, and difficulty specifically isolating many commensal intestinal
bacteria.
We fulfilled Koch’s postulates in a host genotype-specific fashion, using nongnotobiotic methods to show that common commensal Bacteroides species induced
disease in a genetic mouse model of IBD whereas an Enterobacteriaceae species that was
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significantly enriched during spontaneous disease was not itself sufficient for disease
induction. We studied mice with a human-relevant IBD-susceptibility mutation which
spontaneously develop intestinal inflammation resembling human ulcerative colitis.
Antibiotics blocked colitis induction and mice remained disease-free after treatment
cessation but developed disease if subsequently colonized with intestinal contents from
untreated donors or with intestinal contents grown in mixed culture on media selective
for Gram-negative obligate anaerobes. We therefore isolated common commensal
Bacteroides species, introduced them into antibiotic-pre-treated mice, and confirmed
colonization by specific, quantitative re-isolation in culture. Isolates colonized
susceptible and non-susceptible mice equivalently but induced disease exclusively in
susceptible animals, suggesting susceptibility was due to differences in host response
rather than altered colonization susceptibility.
In contrast to commensal Bacteroides, Enterobacteriaceae were >100-fold
enriched in the microbiota during spontaneous disease in our mice, supporting
observations in other animal models and in human patients. However an
Enterobacteriaceae isolate from a spontaneously colitic mouse was not sufficient to
induce disease in antibiotic-pre-treated animals despite robust colonization.
We thus identified distinct subsets of commensals with and without IBD-inducing
potential and showed that these subsets would not have been predicted based on diseaseassociated shifts in the microbiota. Our findings establish experimental criteria and a
conceptual framework for understanding the intestinal microbiota's involvement in IBD.
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CHAPTER 1
Inflammatory Bowel Disease: History and Studies of Etiology

1

Epigraphs

“DR. BURRILL B. CROHN, NEW YORK: In a disease of this type, in which an
attempt is being made to establish the etiology of the disease, we have naturally taken
great pains to exclude every known etiologic factor. Histologic sections were made of the
tissues and stained with various types of stains. Cultures were made. Ground material
was injected into guinea-pigs and fowl. Various types of laboratory animals were used to
eliminate any possible form of tuberculosis. Löwenstein cultures were made. Dr.
Klemperer, the pathologist, exhausted all the known possible scientific methods of finding
an etiologic factor. I can say that no etiologic factor was found.”
“Regional Ileitis: A Pathologic and Clinical Entity.” (1932) Burrill B.
Crohn, MD, Leon Ginzburg, MD, and Gordon D. Oppenheimer, MD.
Journal of the American Medical Association. 99(6):1323–1329.

“In discussing the difficult subject of the etiology of these ulcerative diseases of
the terminal ileum and colon, it seems desirable in the present state of knowledge to be
very conservative and careful in the expression of one’s opinions. While ulcerative colitis
is a fairly definite clinical and pathologic disease picture, it is doubtful if it is an etiologic
entity…
“[I]t does not seem correct to assume that all, or even a large per cent of the
ulcerative colitis cases of unknown etiology are chronic bacillary dysentery… Ulcerative
colitis is usually sporadic; bacillary dysentery is usually epidemic. Ulcerative colitis is
almost never encountered as contact disease; nor do certain geographical localities
furnish more cases than others. Ulcerative colitis usually begins insidiously; bacillary
dysentery is as a rule acute and stormy in its onset….
“Our opinion in the matter of the etiology of chronic ulcerative colitis may be
summarized as follows: (1) a small per cent are unrecognized amoebic colitis cases. (2) a
certain per cent, approximately 20%, are instances of chronic bacillary dysentery in
whom either the dysentery organisms or the secondary invaders, or both, keep up the
disease. (3) the cause in the remainder is as yet unknown… Three theories seem most
plausible: (1) a primary functional (neurogenic) disturbance of the bowel and then a
secondary infection. (2) the mucosa is first sensitized by a transient specific or special
infection and then local or distant organisms or toxins attack the susceptible tissue… (3)
the specific cause, whether bacterial or viral in nature, is yet to be discovered.”
“The Etiology and Therapy of Ulcerative Colitis.” (1936) Asher
Winkelstein, MD. American Journal of Digestive Disease and Nutrition.
3(11): 839-844.
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Inflammatory bowel disease (IBD) consists of a spectrum of chronic, noncommunicable, diarrheal diseases, including ulcerative colitis and Crohn’s disease, that
are characterized by inflammation of the gut wall (Xavier and Podolsky 2007). IBD
affects over 1 million people in the USA alone and is rising in prevalence worldwide
(Loftus 2004). Historical accounts of diseases with IBD-like symptoms date back at least
two millennia to a widely cited description by a Greek physician with the oddly
appropriate name Soranus of Ephesus (De Dombal 1968). The first medical report
describing ulcerative colitis by its modern name is generally credited to Sir Samuel Wilks
in 1859, and ulcerative colitis was formally defined as a discrete pathologic entity
distinguishable from infectious colitis by Wilks and Moxon in 1875 (De Dombal 1968;
Pearce 2009). Crohn, Ginzburg, and Oppenheimer proposed classifying the condition that
is now called Crohn’s disease as an entity distinct from ulcerative colitis in 1932 (Crohn,
Ginzburg et al. 1932). By their classification, which is widely accepted today, ulcerative
colitis and Crohn's disease are characterized respectively by continuous, ascending
colonic inflammation that is restricted to the intestinal mucosa and by discontinuous,
granulomatous inflammation that penetrates the intestinal wall and can occur in any
portion of the intestinal tract (Crohn, Ginzburg et al. 1932; Xavier and Podolsky 2007).
However since ulcerative colitis and Crohn’s disease share many features and cannot be
diagnostically distinguished in a significant fraction of cases, it remains unclear whether
these two forms of IBD share a common etiology, are etiologically distinct, or represent a
collection of similar diseases arising from many different etiologies (Stenson, Hanauer et
al. 2009).
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Beginning with many of the earliest descriptions of IBD in modern medical
literature, attention has focused on the possibility that disease may have a microbial cause
(see epigraphs above). Consistent with IBD’s apparently non-communicable etiology,
both these early investigations and many subsequent studies have failed to consistently
associate most cases with infection by any known microbial pathogen (Crohn, Ginzburg
et al. 1932; Winkelstein 1936; Packey and Sartor 2009). Despite the failure to identify
specific etiologic agents, a wealth of clinical and laboratory data supports the hypothesis
that IBD induction depends on one or more factors within the intestinal tract’s indigenous
microbiota (Strober 2010), which is an extraordinarily dense microbial community
comprising hundreds or thousands of commensal species many of which have never been
grown in culture (Eckburg, Bik et al. 2005; Qin, Li et al. 2010). Medically, antibiotics
and probiotics have therapeutic benefits in several manifestations of IBD (Sartor 2008;
Ohkusa, Kato et al. 2010). In patients with Crohn's disease, surgical diversion of fecal
flow produces disease remission in inflamed bowel segments and disease often recurs
upon flow restoration (Ginzburg, Colp et al. 1939; Harper, Lee et al. 1985; Janowitz,
Croen et al. 1998). Harper and colleagues, studying IBD patients in whom surgical
diversion had been performed, found that experimental introduction of small bowel
effluent into the surgically excluded bowel segments re-induced disease whereas a sterile
ultrafiltrate of bowel effluent did not (Harper, Lee et al. 1985). Similarly, in most
spontaneous animal models of IBD, disease is blocked by antibiotics or re-derivation into
germ-free (gnotobiotic) facilities and IBD-susceptible germ-free animals develop disease
upon exposure to commensal microbiota from conventionally raised hosts (Sartor 2008).
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However it remains a subject of active investigation whether these phenomena represent
the effects of a specific microbial species or subgroup of species, constitute a nonspecific response to microbial stimuli in general, or are due to the synergistic effects of
multiple microbes acting together as a community (Xavier and Podolsky 2007; Sartor
2008; Takaishi, Matsuki et al. 2008; Garrett, Gordon et al. 2010; Strober 2010).
While many questions remain unresolved about the microbial factors responsible
for IBD induction, advances in immunology and genetics have revolutionized
understanding of disease etiology and pathogenesis. IBD is now widely understood to
consist of a pathological host immune response influenced by the complex interaction of
genetic and environmental, as well as microbial, factors (Xavier and Podolsky 2007;
Cadwell, Patel et al. 2010). The basis of the immune response is complex and only
partially understood, but components of both the innate and adaptive immune system are
clearly important with substantial evidence of a critical role for T-cells and therapy
targeting the inflammatory cytokine TNFα is highly efficacious in many cases (RakoffNahoum, Paglino et al. 2004; Xavier and Podolsky 2007; Barnes and Powrie 2009;
Stenson, Hanauer et al. 2009). Classical family-based genetic studies have shown that
IBD has a strong genetic component, but disease is multigenic and genetic factors are not
solely sufficient to explain its occurrence (Stenson, Hanauer et al. 2009). Recent data
from multiple genome-wide association studies has led to identification of susceptibility
alleles at nearly 100 different loci, some specifically associated with either ulcerative
colitis or Crohn’s disease and others associated with both (Barrett, Hansoul et al. 2008;
Franke, Balschun et al. 2008; Franke, McGovern et al. 2010). While the functional
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significance of many loci remain obscure, several are associated with genes in pathways
that modulate immune and epithelial function. Interestingly, these studies have revealed
susceptibility alleles associated with multiple genes in pathways related to Interleukin-10
(IL-10) and Transforming Growth Factor β (TGFβ) signaling, two inhibitory cytokines
that are known from immunologic studies to play a prominent role in immunoregulation
and intestinal homeostasis. In support of these findings, a recent kindred analysis
identified a subset of patients with highly fulminant, rapid-onset enterocolitis due to
recessive deficiencies in components of the receptor complex for IL-10 (Glocker, Kotlarz
et al. 2009).
Identification of disease-inducing microbial agents in a wide variety of diseases
has traditionally relied on experimental infection of laboratory animals. As expemplified
by the first epigraph at the beginning of this chapter, efforts at applying this approach to
IBD using standard healthy animals have largely failed to induce IBD-like disease or
result in identification of causative microbial agents (Crohn, Ginzburg et al. 1932; Packey
and Sartor 2009). Together with epidemiologic clues, these experiments provided some
of the earliest evidence that the IBD’s etiology is more complex than that of a classical
infectious disease (Winkelstein 1936). Subsequent efforts to develop experimental
models simulating IBD have included treating animals with colitis-inducing chemicals or
drugs, transferring specific populations of immune cells into recipients lacking
endogenous lymphocyte, and infecting animals with known enterocolitis-inducing
microbial pathogens (Jurjus, Khoury et al. 2004; Nell, Suerbaum et al. 2010). Each of
these approaches has yielded important information about the immunologic factors,
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cellular pathways, potential therapies, and natural progression of intestinal inflammation.
But with important exceptions (Onderdonk, Franklin et al. 1981; Onderdonk, Bronson et
al. 1987; Cadwell, Patel et al. 2010), inducible models can be problematic for identifying
indigenous microbial factors involved in spontaneous IBD since the proximate cause of
disease in each case involves an experimental manipulation that rarely or never occurs in
association with human disease.
By contrast, the relatively recent availability of technology to create genetically
engineered animal models has rendered it possible to conduct experiments which would
have been unimaginable in the days of Crohn, Wilks, and (especially) Soranus. In the
past two decades, an ever-increasing number of genetic animal models that develop
spontaneous intestinal inflammation resembling human IBD have been developed
(Horwitz 2007). These animal models, primarily mice, bear mutations in genes affecting
many aspects of epithelial integrity and both the adaptive and innate immune systems
(Xavier and Podolsky 2007; Mizoguchi and Mizoguchi 2010). In contrast to unmanipulated healthy animals or animals in which disease has been experimentally
induced, these spontaneously colitic animals have proven to be more natural candidates
for efforts to identify potential IBD-inducing microbes and test hypotheses about the
nature of microbial contributions to IBD etiology (Horwitz 2007; Sartor 2008). As
described in greater detail in subsequent chapters, landmark studies using antibiotics and
re-derivation into germ-free facilities have shown that disease in most of these models is
largely dependent on the commensal microbiota and that it may be possible to identify
specific commensal bacteria which play a role in disease induction (Sartor 2008).
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Remarkably, there are a number of examples of in which deletion of a specific gene was
observed to cause spontaneous intestinal inflammation in mice and the gene was
subsequently shown to be associated with a risk allele for IBD in human patients
(Mizoguchi and Mizoguchi 2010). These convergent lines of evidence raise the
possibility that beyond serving as conceptually useful experimental models, discoveries
in spontaneously colitic animals which bear mutations in genes linked to human IBDsusceptibility alleles may be directly relevant to the etiology and pathogenesis of human
IBD.
One such animal model of particular interest was recently developed and
characterized in collaboration between our laboratory and that of Dr. Paul Allen. The
mice in question bear mutations affecting two different pathways that have each been
identified as associated with IBD. The first genetic alteration in these mice consists of
recessive deficiency in the IL-10 receptor 2 (IL10R2) protein (Spencer, Di Marco et al.
1998), deficiency in which is known to cause severe, fulminant IBD in human patients
within the first year of life (Glocker, Kotlarz et al. 2009). Susceptibility alleles linked to
the IL-10 locus have also been identified for both Crohn’s disease and ulcerative colitis in
recent genome-wide association studies (Franke, Balschun et al. 2008; Franke,
McGovern et al. 2010). The second alteration consists of a transgenic dominant negative
TGFβ receptor II (dnTGFβRII) expressed specifically in T-cells (Gorelik and Flavell
2000). Although we are not aware of a human IBD-susceptibility allele linked directly to
this gene, a recently identified risk allele for Crohn’s disease is linked to the gene
encoding SMAD3 (Franke, McGovern et al. 2010), a signal-transducing protein that is
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phosphorylated upon activation of the TGFβ receptor and is important for TGFβ
induction of Foxp3+ regulatory T cells (Yoshimura, Wakabayashi et al. 2010). Mice
bearing either of these genetic features in isolation develop somewhat variable colitis
over a period of months (Spencer, Di Marco et al. 1998; Gorelik and Flavell 2000; Kang,
Bloom et al. 2008). By contrast, mice that bear both genetic features, which we termed
“dnKO mice”, all spontaneously develop fulminant intestinal inflammation with
pathologic hallmarks of severe human ulcerative colitis by 4-6 weeks of age (Kang,
Bloom et al. 2008). To the extent of our knowledge, disease in this model is considerably
more rapid and robust than in other spontaneous genetic models (Kang, Bloom et al.
2008). Co-housed littermate Il10r2+/- controls do not develop colitis, suggesting that any
microbial triggers of colitis in dnKO mice are innocuous in exposed, non-susceptible
hosts. Disease in dnKO mice is characterized by elevated Th1 serum cytokines, is
partially ameliorated by neutralization of the cytokines TNFα and interferon-γ, and can
be induced in Rag-/- recipient mice by adoptive transfer of CD4+ T-cells from dnKO
donors (Kang, Bloom et al. 2008).
The aim of my doctoral research has been to determine whether microbial factors
are important for the etiology of colitis in dnKO mice and, if so, to identify specific
bacteria that play a role in disease induction. Chapter 2 of this thesis describes
experiments demonstrating that colitis in dnKO mice is completely responsive to
medically relevant antibiotic treatment and suggesting that disease may be due to a
specific subset of anaerobic bacteria. Chapter 3 describes development of an
experimental system to test the disease-inducing potential of various commensal
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microbes, fulfillment of host-genotype-specific Koch’s postulates for a number of
commensal Bacteroides isolates in dnKO mice, and demonstration that although
commensal Enterobacteriaceae are greatly enriched during spontaneous disease, an
Enterobacteriaceae isolate is not itself sufficient for disease induction. Chapter 3 also
addresses similarities and differences between our findings in dnKO mice and results
from other animal models with human-relevant IBD-susceptibility mutations and
proposed both experimental criteria and a conceptual framework for further elucidating
commensal microbial influences on IBD etiology. Chapter 4 discusses potential future
directions arising from these findings.
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Chapter 2:
The dnKO mouse model of fulminant IBD is highly antibiotic responsive

11

INTRODUCTION
Many animal models of IBD are highly dependent on the intestinal microbiota
(see Chapter 1) (Horwitz 2007). The clearest and most definitive demonstration of
microbiota dependency has involved re-deriving animal models into germ-free facilities
and demonstrating the absence of disease. Prominent examples in which this strategy has
prevented intestinal disease include spontaneous genetic models such as HLA-B27
transgenic rats (Taurog, Richardson et al. 1994), IL-10 deficient mice (Sellon,
Tonkonogy et al. 1998), T cell receptor-αβ-deficient mice (Dianda, Hanby et al. 1997),
and TRUC (Tbet-/- x Rag-/-) mice (Garrett, Gallini et al. 2010). Germ-free derivation also
greatly mitigated colitis development in IL-2 deficient mice (Schultz, Tonkonogy et al.
1999). Germ-free re-derivation has also prevented or mitigated intestinal inflammation in
a number of inducible colitis models that are sometimes used to model IBD, including
carrageenan treatment of guinea pigs (Onderdonk, Hermos et al. 1977), dextran sodium
sulfate (DSS) treatment of mice (Pull, Doherty et al. 2005), and transfer of
CD4+CD45Rbhigh T cells into Rag-/- recipient mice (Mazmanian, Round et al. 2008).
These and similar experiments have been of foundational importance, and germfree re-derivation may be regarded as a “gold standard” in demonstrating the importance
of microbial contributions to disease in a given animal model. However due to both
practical reasons and a desire to more accurately simulate the situation in human IBD
patients, there is also strong interest in exploring the role of intestinal microbe in animal
models through use of antibiotics. Antibiotic treatment has proven efficacious to some
extent in a wide variety of animal colitis models including HLA-B27 transgenic rats
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(Rath, Schultz et al. 2001), IL-10 deficient mice (Hoentjen, Harmsen et al. 2003), TRUC
(Tbet-/- x Rag-/-) mice (Garrett, Lord et al. 2007), DSS-treated mice (Rakoff-Nahoum,
Paglino et al. 2004), and DSS-treated, murine norovirus-infected, Atg16L1 hypomorphic
mice (Cadwell, Patel et al. 2010). The antibiotics used have varied from study to study,
but a common theme in the majority of models has been that antibiotics with anaerobic
coverage, particularly metronidazole, are partially or entirely efficacious. Some studies
have distinguished between the ability of antibiotics to prevent disease before it becomes
established and to therapeutically treat disease after it has already developed (Rath,
Schultz et al. 2001; Hoentjen, Harmsen et al. 2003), a question with importance both for
understanding disease pathogenesis and for potential relevance to medical therapies.
We assessed whether microbial factors were important in the dnKO mouse model
of fulminant, rapid-onset IBD by treating mice with metronidazole and ciprofloxacin
(Kang, Bloom et al. 2008). We found that disease was highly antibiotic-responsive, with
antibiotics completely preventing colitis by a variety of semi-quantitative and quantitative
metrics. We also found that treatment with metronidazole and ciprofloxacin could
therapeutically reverse even severe colitis, reproducing classic features of quiescent IBD
in treated animals. In smaller-scale experiments we further found that metronidazole
monotherapy was partially efficacious in preventing disease but did not appear to be
therapeutically efficacious in established disease, while ciprofloxacin monotherapy did
not appear to have either preventive or therapeutic efficacy.

13

METHODS AND RESULTS
Generation of dnKO mice (developed by Silvia S. Kang and Paul M. Allen)
Dominant negative TGFβRII mice (supplied by Richard A. Flavell) (Gorelik and
Flavell 2000) and CRF2–4-deficient (IL-10R2−/−) mice (Genentech) (Spencer, Di Marco
et al. 1998) were on the C57BL/6 background. All mice used in these experiments were
bred and housed in the specific pathogen-free barrier facility on the 7th floor of the
Clinical Sciences Research Building at Washington University. Animal protocols were
reviewed and approved by the Washington University animal studies committee. The
Crf2–4−/− mice lack the IL-10R2 receptor protein and are referred to as Il10r2−/− in this
report. The dominant negative TGFβRII mice (referred to as dnTgfβrii) express a
dominant negative TGFβRII solely in the CD4 and CD8 compartment. Mice that were
unresponsive to IL-10R2 signaling in all compartments and TGFβ signaling specifically
in the T cell compartment were generated by breeding dnTgfβrii mice (hemizygous) with
Il10r2−/− mice to yield a novel strain of mouse, dnTGFβRII (hemizygous) × Il10r2−/−,
henceforth referred to as dnKO mice. The breeding scheme involved mating dnTGFβRII
(hemizygous) × Il10r2+/−, mice with Il10r2−/− mice to generate four genotypes of
littermates in equal Mendelian ratios: dnKO, Il10r2−/−, dnTGFβRII (hemizygous) ×
Il10r2+/−, (referred to as dnTGFβRII), and Il10r2+/− mice (which phenotypically resemple
wild-type animals).
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Antibiotic treatment blocks development of fulminant disease in dnKO mice
At 2 weeks of age, the intestines of dnKO mice appeared normal both
macroscopically and microscopically (Kang, Bloom et al. 2008). This observation
indicated that general intestinal architecture development in these mice was not perturbed
at this time. Disease induction was rapid and could be detected by 3 weeks of age, a time
commensurate with known changes in the microbial ecology of the mammalian intestine
that occur at the weaning–suckling transition(Palmer, Bik et al. 2007). We therefore
explored the role of intestinal microbes at or after the suckling-weaning transition (3
weeks of age).
To examine whether bacteria influence disease development in the dnKO model,
we treated mice with broad-spectrum antibiotics in drinking water. Beginning at 24 d of
age, mice received drinking water containing high-dose ciprofloxacin and metronidazole,
two commonly used antibiotics that are broadly active against aerobic and anaerobic
bacterial species, respectively (Perencevich and Burakoff 2006). Mice received drinking
water containing 0.66 mg/ml ciprofloxacin (Ahmed, van Vianen et al. 2003) and 2.5
mg/ml metronidazole (Sigma) (Roach, Wallis et al. 1988) beginning at 24 d of age.
Previous reports (Rath, Schultz et al. 2001) have suggested occasional refusal of mice to
drink water that contains antibiotics, so we included 20 mg/ml sugar-sweetened grape
Kool-Aid Mix (Kraft Foods) in the water to encourage consumption. The antibiotic
solution was passed through a sterilizing, 0.22-μm, nonpyrogenic cellulose acetate filter
(Corning) before delivery to mice and was replaced with freshly prepared solution two to
three times per week.
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Antibiotic treatment blocked development of fulminant disease in treated dnKO
with a high degree of efficacy as assessed by survival and weight gain. Mice were
weighed every 1-2 days using a portable electronic Ohaus scale (VWR International).
Weights were recorded to a tenth of a gram. Individual mice died or were humanely
killed when their weight reached ≤ 70% of their maximal weight and 45-day survival was
analyzed by the Kaplan-Meier method. Untreated mice rapidly developed fulminant, fatal
disease (45-day survival = 10.5%; median survival = 35 days). In striking contrast,
antibiotic-treated dnKO mice exhibited 100% 45-d survival (Figure 2.1), a highly
significant difference (p < 0.0001). We were thus able to compare the growth of treated
dnKO mice with treated littermate controls (Il10r2−/−, dnTGFβRII, and Il10r2+/−
combined) by measuring their weights over a 3-wk treatment period (Figure 2.2). Both
groups of mice showed weight gain over the course of the experiment, and no statistically
significant difference in weight gain was observed between the dnKO and control groups
(p = 0.105). These results indicated that antibiotic treatment effectively blocked
fulminant disease.

Antibiotic treatment blocks colonic gross pathology in dnKO mice
We next assessed development of intestinal pathology in antibiotic-treated dnKO
mice. Disease severity was assessed using a gross pathology scoring system previously
validated in this model (Kang, Bloom et al. 2008). Upon sacrifice, mice were euthanized
and ceca and colons were immediately removed, flushed with PBS and Bouin's fixative
(70% picric acid / 25% formaldehyde [37%] / 5% glacial acetic acid), and opened
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longitudinally with scissors (ceca were opened from the ileocecal junction to the cecal tip
along the greater curvature). The intestines were then pinned open mucosa-upward in
square Petri dishes filled with wax (Carolina Biological), fixed in Bouin’s fixative for 4-8
hours at 4°C, washed and stored in 70% ethanol. Whole mount images of fixed intestines
were taken at 7X (cecum only), 20X, 40X, and 90X magnification. Images were scored
for gross pathology according to a previously validated scoring system (Kang, Bloom et
al. 2008) by an anatomic pathologist (T.S.S.) blinded to the identity of the samples (0 =
no disease, 3 = severe disease; representative images of ceca with different degrees of
disease severity are shown in Figure 2.3).
Intestinal gross pathology was assessed in a cohort of age-matched, 4 week old
dnKO and Il10r2+/- mice that were either left untreated or were treated with antibiotics
beginning at weaning (age 3 weeks). Consistent with previous observations (Kang,
Bloom et al. 2008), we observed development of severe intestinal pathology in the cecum
and transverse colon of untreated dnKO but not Il10r2+/- mice. However antibiotic
treatment completely blocked pathology development in treated dnKO mice. The
differences among groups were highly statistically significant (p = 0.0033 in both the
cecum and transverse colon by Kruskal-Wallis test), although the groups were
underpowered for individual pairwise comparisons. Similar results were obtained in
dnKO mice treated with antibiotics for longer time periods (not shown).
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Antibiotic treatment blocks colitis development in dnKO mice
We next assessed the effects of antibiotic treatment on histologic colitis in dnKO
mice. Intestines were encased in 2% agar, turned on their sides (perpendicular to plane of
microtome), paraffin embedded, cut in 5-μm sections, and stained with hematoxylin and
eosin (H&E) at the Developmental Biology Department histology core (Washington
University, St. Louis, Missouri, United States). Colonic histology of untreated dnKO
mice exhibited severe mucosal inflammation with features including crypt abscessess,
mucosal thickening, inflammatory infiltrates, epithelial hyperproliferation, crypt dropout,
and other features characteristic of human ulcerative colitis (Figure 2.5) (Kang, Bloom et
al. 2008). By contrast, colons of antibiotic-treated dnKO mice and both treated and
untreated Il10r2+/- mice showed no histologic evidence of colitis (Figure 2.5).
To better quantify disease, we measured increases in crypt height and crypt width,
hallmark features of the epithelial response to colonic inflammation which we have
previously shown to be highly sensitive and precise metrics of disease (Kang, Bloom et
al. 2008). Blinded microscopic analysis of H&E-stained histologic samples for height and
width of well-oriented crypts in the transverse colon, and distal 0.5 cm of the rectum was
performed at 400X magnification. By these metrics untreated dnKO mice were highly
significantly more colitic than all other groups including antibiotic-pre-treated dnKO
mice, which did not differ from Il10r2+/- controls (Figure 2.6). Thus, antibiotic treatment
with metronidazole and ciprofloxacin completely blocked colitis development in dnKO
mice.
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Antibiotic treatment prevents mortality and reverses weight loss in severely colitic
dnKO mice.
Given the ability of metronidazole and ciprofloxacin combination therapy to
prevent colitis in dnKO mice, we next asked whether these antibiotics would also have a
therapeutic role in treated established disease. To assess treatment efficacy, we allowed a
group of 5 dnKO mice to age and become phenotypically sick before initiating treatment.
Mice aged ≥28 days were begun on metronidazole and ciprofloxacin combination therapy
if they fell below 90% of their maximum and had lost weight on 3 consecutive days or if
they fell below 80% of their maximum body weight. (All mice were aged 28-32 days at
beginning of treatment.) Two untreated age-, sex-, and weight-matched dnKO mice
retrospectively identified from previous survival experiments were selected as controls
for each antibiotic-treated mouse (total of 10 untreated control mice). Mice were weighed
daily and sacrificed according to humane guidelines as described above.
We found that treatment with metronidazole and ciprofloxacin reversed even
advanced disease in dnKO mice. Antibiotics resulted in significantly improved survival
and weight gain (Figure 2.7). Whereas untreated matched control mice had a median
survival of just 5 days, the treated mice exhibited significantly enhanced survival (p =
0.016, logrank test) and 3 out of 5 exhibited substantial and prolonged weight gain
(Figure 2.7). Of the two treated mice that succumbed, one died within the first day of
treatment (presumably before antibiotics could take effect; pathology not analyzed). The
second survived longer than all untreated control mice before being sacrificed for humane
reasons due to weight loss after 17 days of treatment. However its cecum and colon were
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subsequently observed to be non-colitic, suggesting the weight loss occurred for extraintestinal reasons.

Antibiotic treatment of severely colitic dnKO mice reverses mucosal thickening and
ulceration and induces unusual gross mucosal characteristics
We next assessed the effects on the colonic mucosa of antibiotic treatment in
severely colitic mice. Healthy colonic mucosa, such as that present in Il10r2+/- mice
(Figure 2.8 A) or in dnKO mice treated with antibiotics prior to colitis development
(Figure 2.8 B) has a relatively even mucosal surface with regular, densely packed crypts
with circular openings. In severe colitis (Figure 2.8 C), colonic mucosa undergoes
ulceration and thickening with crypt dropout (loss of many crypts), development of
thickened and dysmorphic crypt openings, and occasional formation of pseudopolyps
(areas of residual mucosa surrounded by ulceration). The colons of successfully treated,
previously colitic dnKO mice were less thickened than colons of untreated dnKO mice (if
thickened at all) and were not ulcerated, but they were grossly dysmorphic due to the
residual damage from inflammation (Figure 2.8 D to F). They exhibited fewer crypts per
unit area (a phenomenon known as atrophy (Riddell, Goldman et al. 1983)), less even
surface, and residually dysmorphic crypt openings. Thickening of the colon in Figure 2.8
E and F is completely reversed and many areas are evident which are completely lacking
in crypts although they are not ulcerated. The remaining crypts are clustered in small
“islands” (usually two crypts together in a doublet), suggestive of post-colitic crypt
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fission (division). All of these features are suggestive of healing mucosa still exhibiting
the after-effects of severe colitis.

Antibiotic treatment of severely colitic dnKO mice reverses inflammation and
induces mucosal characteristics with classic features of quiescent IBD
Remarkably, we found that antibiotic treatment in severely colitic mice produced
the stereotypical histologic hallmarks of quiescent colitis (quiescent IBD). Figure 2.9
shows images of the colon of formerly colitic mice rescued with antibiotics. Colitis has
largely disappeared, with reduced inflammatory infiltrates, little or no hyperplasia, and
signs of healthy epithelial cells including mature, polarized surface epithelium and a
relatively normal census of mature goblet cells. However the mucosa remains severely
dysmorphic structurally with distorted branching and budding crypts – some showing
separation from the muscularis mucosae – and widespread crypt dropout (atrophy). There
are also epithelium-lined cyst-like structures that may represent the sites of former crypt
abscesses. Colons from formerly colitic mice thus exhibit the classic features of quiescent
colitis or quiescent IBD, which is seen in IBD patients whose colitis is in remission
(Riddell, Goldman et al. 1983).
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Metronidazole monotherapy provides survival benefit to dnKO mice before disease
develops, but metronidazole treatment in established disease or ciprofloxacin alone
does not.
We next asked whether metronidazole or ciprofloxacin played a more important
role in colitis treatment in dnKO mice by treating with each of them individually. We
treated mice either at weaning (21 days of age) or at ≥24 days of age. We observed that
there were substantial survival benefits for mice treated with metronidazole at weaning,
but not for any of the other groups (p < 0.0001). Although sample sizes in most groups
were small and have not been repeated, the results are strongly suggestive that
metronidazole treatment is of primary importance early in disease, although combination
therapy may be more efficacious and appears required later in disease. Given the
microbial species targeted by metronidazole (Perencevich and Burakoff 2006), these
results suggested that obligate anaerobes might play a crucial role in disease induction in
dnKO mice.

DISCUSSION
In many animal models of spontaneous IBD, disease is known to be microbiota
dependent (Horwitz 2007). Antibiotic treatment has been one important tool for
examining microbiota dependence of disease. Here we examined the effects of treatment
with the antibiotics metronidazole and ciprofloxacin on colitis in the medically relevant
dnKO mouse model of disease. We found that metronidazole and ciprofloxacin
combination therapy were highly efficacious in completely preventing colitis in dnKO by
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several metrics of disease and also efficacious in treatment of established disease.
Importantly, mice successfully treated after development of severe disease showed
classic colonic epithelial features seen in human patients with quiescent IBD, which may
be important precursors to IBD-associated colon cancer (Greenstein, Sachar et al. 1979;
Riddell, Goldman et al. 1983; Itzkowitz 2003). We further found that metronidazole
monotherapy was more efficacious than ciprofloxacin monotherapy in preventing
disease, although neither appeared as efficacious as combination therapy.
This is not the first study to explore the efficacy of antibiotics in murine IBD
(Hoentjen, Harmsen et al. 2003; Rakoff-Nahoum, Paglino et al. 2004; Heimesaat,
Bereswill et al. 2006; Garrett, Lord et al. 2007). However previous studies have either
relied on experimentally administered agents to induce inflammation or on mouse strains
that develop less severe forms of spontaneous IBD in which treatment efficacy is
primarily assessed on the basis of histology scores without additional important metrics
such as survival, weight gain, gross pathology, serum cytokine levels, and T cell
activation (Kang, Bloom et al. 2008). We are aware of no other models in which
antibiotic treatment has produced clinical disease remission and histologic healing as
dramatic as that which we observe in antibiotic-treated dnKO mice. Our findings have
similarities to those in HLA-B27 transgenic rats, where metronidazole monotherapy had
preventive efficacy but not therapeutic efficacy in established disease, although that study
observed some preventive efficacy of ciprofloxacin as well (Rath, Schultz et al. 2001).
Metronidazole and ciprofloxacin combination therapy was not assessed.
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Although antibiotics, including ciprofloxacin and metronidazole, are sometimes
used to treat patients with IBD, research regarding their efficacy remains inadequate.
Yamada’s Textbook of Gastroenterology comments on a “surprising absence of
controlled data supporting the use of antibiotics in patients with Crohn’s disease”,
(Stenson, Hanauer et al. 2009), although a meta-analysis demonstrated beneficial effects
of broad-spectrum antibiotic treatment (Rahimi, Nikfar et al. 2006). To our knowledge,
the utility of metronidazole and ciprofloxacin combination therapy in ulcerative colitis
has not been adequately assessed (Sartor 2003; Gionchetti, Rizzello et al. 2006;
Perencevich and Burakoff 2006), and recommendations vary regarding usage in patients
with fulminant ulcerative colitis (Cuffari, Present et al. 2005; Baumgart and Sandborn
2007; Ho, Lees et al. 2007). However a recent randomized, double-blind, placebocontrolled trial of a 2-week course of broad-spectrum antibiotics (amoxicillin,
tetracycline, and metronidazole) in ulcerative colitis patients found significant short- and
long-term benefits in terms of both clinical disease and mucosal healing, with treatment
providing greater benefit in patients with more active disease (Ohkusa, Kato et al. 2010).
Our results suggest that carefully controlled studies examining the benefits of combined
ciprofloxacin and metronidazole in ulcerative colitis may also be appropriate.
Our findings suggest not only that disease in dnKO mice is microbiota-dependent,
but that it might depend on specific microbial factors. The antibiotic regimen we used
does not sterilize the gut (Heimesaat, Bereswill et al. 2006; Swidsinski, Loening-Baucke
et al. 2008), suggesting that a germ-free state is not required for complete blockade of
disease. Furthermore, the observation that metronidazole monotherapy had preventive
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effects suggests that disease may depend in significant proportion on anaerobic microbes
in the gut, given the known action and coverage of metronidazole (Rath, Herfarth et al.
1996; Perencevich and Burakoff 2006). Based on the results described here, we
hypothesize that disease in dnKO mice depends on a subset of commensal bacteria, likely
obligate anaerobes, which are eliminated by antibiotic treatment.
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Figure 2.1: Treatment with ciprofloxacin and metronidazole promotes survival in
dnKO mice.
45-day survival of untreated dnKO mice (n = 19; 45-d survival = 10.5%; median survival
= 35 d) and dnKO mice receiving metronidazole and ciprofloxacin in drinking water
beginning at 24 days of age (n = 8; 45-d survival = 100%). Individual mice died or were
humanely killed when their weight reached ≤ 70% of maximal weight. Survival was
analyzed by the Kaplan-Meier method, and statistical significance of difference between
groups is p < 0.0001, by log-rank test. Upward arrow, antibiotic treatment begun at age
24 d. (Kang, Bloom et al. 2008). Representative of multiple independent experiments. All
statistical analysis was performed using Prism v3.02 (GraphPad Software) unless
otherwise indicated. (Some survival data was generated by Silvia S. Kang).
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Figure 2.1
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Figure 2.2: Treatment with ciprofloxacin and metronidazole promotes weight gain
in dnKO mice.
Weight gain of antibiotic-treated mice (n = 2 Il10R2+/-, n = 3 Il10R2-/-, n = 4 dnTgfβrii,
and n = 7 dnKO) plotted individually (A) or as mean weights (B) of treated dnKO mice
(n = 7) and treated controls (n = 9; non-dnKO genotypes combined) ± SEM. Data were
pooled from three separate experiments using dnKO and littermate controls. To account
for the longitudinal nature of the data, analysis of weight change over the course of
treatment was performed using generalized estimating equations. The mice gained weight
over the course of the experiment (p < 0.001), and the dnKO and control groups did not
differ significantly (p = 0.105). Statistical analysis was performed by Michael J. Geske
(Kang, Bloom et al. 2008). Representative of multiple independent experiments
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Figure 2.3: Scoring system for intestinal gross pathology.
Representative cecal whole mount samples imaged at 7X, 20X, 40X, and 90X
magnification using an Olympus SZX12 dissecting microscope with an Olympus DP70
Digital Microscope Camera at 1360x1024 image size (Diagnostic Instruments). Samples
were scored by an anatomic pathologist (T.S.S.) blinded to the identity of the samples
according to a previously validated scoring system: 0, normal; 1, focal ulcers present; 2,
ulcers and diffuse, mild mucosal thickening; and 3, ulcers and diffuse, severe mucosal
thickening (Kang, Bloom et al. 2008). Samples in which different areas of the image
most closely matched different scoring criteria were assigned the average of the two
scores. 7X scale bar = 6 mm; 20X scale bar = 2 mm; 40X scale bar = 1 mm; 90X scale
bar = 0.44 mm.
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Figure 2.4: Treatment with ciprofloxacin and metronidazole blocks colonic gross
pathology in dnKO mice.
Cecum and transverse colon pathology scores of 4-week-old untreated and antibiotictreated Il10r2+/- and dnKO mice. Abx = antibiotics (metronidazole + ciprofloxacin in
drinking water). Intestinal whole mounts were scored for gross pathology in a blinded
fashion by an anatomic pathologist (T.S.S.) according to a validated system: 0 = no
pathology, 3 = severe pathology (see Figure 2.3). Individual (squares) and median (bars)
pathology scores are displayed. Kruskal-Wallis test:
(A) Cecum pathology score: H 3 = 13.75, p = 0.0033.
(B) Transverse colon pathology score: H 3 = 13.75, p = 0.0033.
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Figure 2.5:

Treatment with ciprofloxacin and metronidazole blocks colonic

inflammation in dnKO mice.

Representative images of H&E stained rectal histology of 4-week-old untreated and
antibiotic-treated Il10r2+/- and dnKO mice as described in Figure 2.4. Representative
images of rectal histology (≤0.5 cm from the anorectal junction) were taken using an
Olympus DP70 Digital Microscope Camera on an Olympus BX51 microscope. The
rectum of the untreated dnKO mouse exhibits mucosal thickening, inflammatory
infiltrates, epithelial hyperproliferation, crypt dropout, and other features characteristic of
human ulcerative colitis (Kang, Bloom et al. 2008). The features of inflammation are
absent from the rectum of the antibiotic-treated dnKO mouse. Scale bar = 100 µm.
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Figure 2.6: Treatment with ciprofloxacin and metronidazole prevents colitis in
dnKO mice as assessed by quantitative metrics of the epithelial response to
inflammation.
Heights and widths of well-oriented crypts from the transverse colons and rectums of 4week-old untreated and antibiotic-treated Il10r2+/- and dnKO mice as described in Figure
2.4. Data displayed as mean +/- SEM. Statistical significance determined by 1-way
ANOVA with post-hoc Tukey’s test. All statistically significant pairwise comparisons are
displayed: **, p < 0.01, ***, p < 0.005.
(A) Transverse colon crypt height: F 3,11 = 40.87, p < 0.0001.
(B) Transverse colon crypt width: F 3,11 = 10.71, p = 0.0014.
(C) Rectum crypt height: F 3,11 = 33.25, p < 0.0001.
(D) Rectum crypt width: F 3,11 = 9.501, p = 0.0022.
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Figure 2.7: Treatment with ciprofloxacin and metronidazole prevents mortality and
reverses weight loss in severely colitic dnKO mice.
dnKO mice (n = 5) treated with metronidazole + ciprofloxacin after developing severe
disease (≥ 4 weeks of age) were each matched with two untreated age-, sex-, and weightmatched dnKO mice (n = 10 total untreated mice). Antibiotic treatment resulted in (A)
significantly improved 25-day survival (p = 0.016, logrank test) and (B) weight gain as
compared to controls. One antibiotic-treated mouse died during the first day of treatment;
necropsy was not performed. A second antibiotic-treated mouse was sacrificed for
humane reasons due to weight loss after 17 days of treatment and observed to be noncolitic. Data compiled from multiple independent experiments with 1-2 mice per group.
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Figure 2.8: Treatment with ciprofloxacin and metronidazole reverses established
colitis in dnKO mice, producing grossly dysmorphic colonic mucosa with evidence
of crypt dropout.
Whole mount images of descending colon mucosa.
(A) 4 week old Il10r2+/- and (B) dnKO mice treated with antibiotics before onset of
severe disease (metronidazole + ciprofloxacin begun at 21 days of age). Colons exhibit
even mucosal thickness with dense, regularly spaced, circular crypt openings.
(C) Descending colon from an untreated, severely colitic 4 week old dnKO mouse
exhibiting areas of frank mucosal ulceration surrounding a pseudopolyp with evidence of
crypt dropout (atrophy) and hyperplastic, grossly dysmorphic crypt openings.
(D to F) Descending colon mucosa from dnKO mice treated with antibiotics begun at ≥4
weeks of age (after development of severe colitis) and continued for ≥17 days.
(D) Colon exhibits no frank ulceration but has uneven mucosal thickness and residually
dysmorphic crypt architecture due to prior disease.
(E) Colon is not thickened or ulcerated but exhibits severe diffuse crypt dropout as
demonstrated by the reduced number of crypts per unit area, Pattern of crypts in doublets
and “islands” suggests the occurrence of crypt fission.
(F) Magnified image of colon in (E), inset.
Bar = 1 mm.
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Figure 2.9: Treatment with ciprofloxacin and metronidazole reverses established
colitis in dnKO mice, producing histologic hallmarks of quiescent ulcerative colitis.
Images of H&E stained descending colon histology from 4-week old (A) Il10r2+/- and
(B) dnKO mice treated with antibiotics before onset of severe disease (see Figure 2.8).
Colons exhibit normal crypt architecture with absence of immune infiltrates and dense,
regularly spaced, non-branching colonic crypts that extend to the muscularis mucosae.
(C) Descending colon from an untreated, severely colitis 4-week old dnKO mouse
exhibiting marked mucosal thickening, infiltration of inflammatory cells, ulceration,
thinning of surface epithelium, epithelial hyperplasia in crypts, and crypt dropout. Images
of (D-E) descending colon and (F) transverse colon from a dnKO mouse treated with
antibiotics after developing severe colitis. Colon exhibits dramatic reductions in mucosal
inflammation and crypt hyperplasia with mature surface epithelium and presence of
goblet cells, especially in the transverse colon. Mucosa shows classical features of
quiescent colitis including widespread crypt dropout (atrophy) and exhibit distorted,
branching crypts (arrows), some of which are separated from the muscularis mucosae,
and epithelium-lined cyst-like structures that may represent former crypt abscesses
(Riddell, Goldman et al. 1983).
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Figure 2.10: Metronidazole monotherapy begun at weaning provides survival
benefit to dnKO mice, but metronidazole monotherapy begun later or ciprofloxacin
monotherapy at either age does not.
45-day survival of dnKO mice treated with metronidazole or ciprofloxacin beginning at
the indicated ages. Survival differences between groups are statistically significant (p <
0.0001, log-rank test). Survival data for metronidazole therapy begun at 21 days of age
are representative of multiple independent experiments; other groups consist of compiled
data from ≥2 experiments each with 1-3 mice per group.

44

Figure 2.10

45

CHAPTER 3
Commensal Bacteroides fulfill host-genotype-specific Koch’s postulates in the dnKO
mouse model of inflammatory bowel disease
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INTRODUCTION
The commensal microbiota is widely recognized to play a critical role in the
pathogenesis of inflammatory bowel disease (IBD) (Xavier and Podolsky 2007). But
despite many decades of research (Winkelstein 1936; De Dombal 1968; Packey and
Sartor 2009), there is no clear consensus on precisely how intestinal microbes induce IBD
(Strober 2010). In particular, two related and fundamentally important questions remain
unresolved: (1) is IBD induced by specific subsets of commensal bacteria and, if so, (2)
can these subsets be identified based on disease-associated alterations in levels of
colonization?
One approach to answering these questions has involved profiling the microbiota
of affected individuals, a strategy recently revolutionized by the widespread availability
of culture-independent mass sequencing that is an important ongoing focus of the Human
Microbiome Project (Peterson, Frank et al. 2008; Peterson, Garges et al. 2009). Profiling
studies have detected complex IBD-associated alterations in microbiota composition but
have not found disease to be consistently associated with presence or absence of a
specific microbe (Frank, St Amand et al. 2007; Takaishi, Matsuki et al. 2008; Packey and
Sartor 2009; Frank, Robertson et al. 2010; Qin, Li et al. 2010). These findings have led
some to theorize that community-wide alterations in the microbiota rather than specific
microbiota elements may be responsible for disease (Garrett, Gordon et al. 2010),
whereas others have suggested that groups of microbes which are enriched during disease
likely play a pro-colitic role while microbes which are depleted may be antiinflammatory (Sokol, Pigneur et al. 2008; Takaishi, Matsuki et al. 2008). But although
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profiling studies have provided invaluable insights into the microbiota dynamics
associated with disease, they have not directly addressed the question of causality (Frank,
St Amand et al. 2007; Peterson, Garges et al. 2009). It thus remains an open question
among many researchers whether fulfilling Koch’s postulates for individual bacterial
species is relevant to IBD and whether disease-associated alterations in microbial
colonization are predictive of underlying disease etiology (Xavier and Podolsky 2007;
Takaishi, Matsuki et al. 2008; Cerf-Bensussan and Gaboriau-Routhiau 2010; Garrett,
Gordon et al. 2010).
Directly assessing disease-inducing roles of specific microbes in IBD in a
reductionist fashion by applying Koch's postulates has proved challenging for several
reasons (Burke 1997). Although progress has recently been made, there is a paucity of
spontaneous animal models exhibiting rapid disease onset that bear human-relevant
disease susceptibility mutations, with some models taking months to develop even
relatively mild disease (Kang, Bloom et al. 2008). Furthermore, experiments using IBDsusceptible animal models have generally relied on gnotobiotic (germ-free) animals
(Horwitz 2007; Sartor 2008). Gnotobiotic animal models have provided many
foundational insights into the microbiota’s influence on both homeostatic development of
the immune system and on intestinal diseases (Mazmanian, Liu et al. 2005; Ivanov,
Atarashi et al. 2009; Round and Mazmanian 2009). However it is not always clear how
directly findings from these models translate to conventionally raised animals or to
humans since many of the microbes tested have been human-derived isolates rather than
rodent-adapted strains, there are well-documented examples of intestinal bacteria
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inducing dramatically different disease phenotypes in gnotobiotic and conventionally
raised hosts (Rhee, Wu et al. 2009; Garrett, Gallini et al. 2010), and gnotobiotic animals
are immunologically underdeveloped, which could have important effects on patterns of
immunopathology (Mazmanian, Liu et al. 2005; Atarashi, Nishimura et al. 2008; Ivanov,
Atarashi et al. 2009; Round and Mazmanian 2009). The intestinal microbiota's vast
diversity and variability (Turnbaugh, Quince et al. 2010) has posed a further challenge
for identification of candidate disease-inducing bacteria, and specifically isolating and
cultivating many intestinal bacteria has been prohibitively difficult (Savage 1977;
Eckburg, Bik et al. 2005; Sartor 2008).
Despite these challenges, important progress has been made through screening of
specific bacteria or defined bacterial mixtures for disease induction in gnotobiotic animal
models. In most models, including Il10-/- mice (Kim, Tonkonogy et al. 2007), Il2-/- mice
(Waidmann, Bechtold et al. 2003), TRUC (Tbet-/- x Rag-/-) mice (Garrett, Gallini et al.
2010), and HLA-B27 transgenic rats (Rath, Herfarth et al. 1996; Rath, Wilson et al.
1999), certain bacteria or bacterial pools have been sufficient for disease induction
whereas others have not, suggesting microbial specificity may be important in disease
induction (Sartor 2008). Broader interpretation of findings is difficult since particular
bacteria have produced different and sometimes apparently contradictory effects in
different animal models (Rath, Wilson et al. 1999; Waidmann, Bechtold et al. 2003; Kim,
Tonkonogy et al. 2007). Surprisingly, isolates of IBD-enriched bacteria from human
patients have frequently failed to induce disease in gnotobiotic experiments whereas
other bacteria have been colitogenic (Rath, Herfarth et al. 1996; Sellon, Tonkonogy et al.
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1998) However as noted above there are several reasons why these results may not
directly translate to human disease, including the fact that the isolates were not hostspecies-adapted. In a pioneering series of studies focusing on host-adapted bacteria,
Onderdonk and colleagues isolated a panel of commensal bacteria from guinea pigs and
screened them in gnotobiotic guinea pigs treated with the colitis-inducing molecule
carrageenan. These studies identified Bacteroides vulgatus as crucial for disease
pathogenesis (Onderdonk, Franklin et al. 1981; Onderdonk, Bronson et al. 1987;
Onderdonk 2005). B. vulgatus also specifically induced colitis in gnotobiotic HLA-B27
transgenic rats (Rath, Herfarth et al. 1996; Rath, Wilson et al. 1999), but it did not induce
disease in the more widely studied Il10-/- mouse model (Sellon, Tonkonogy et al. 1998)
and was actually protective against colitis in Il2-/- mice (Waidmann, Bechtold et al.
2003). It is unclear which, if any, of these seemingly contradictory findings most
realistically mimics the situation in human disease.
Based on our previous findings (Chapter 2), we hypothesized that disease in the
antibiotic-responsive, rapid-onset, medically relevant dnKO mouse model of spontaneous
IBD depends on a subset of commensal bacteria, likely obligate anaerobes, which are
eliminated by antibiotic treatment. Here we use non-gnotobiotic methods to fulfill hostgenotype-specific Koch's postulates for commensal Bacteroides species in dnKO mice.
Based on screening experiments, we isolate commensal intestinal bacteria from our
mouse colony, introduce them into antibiotic-pre-treated mice, assess disease
development, and confirm host colonization by quantitatively re-isolating the
experimentally introduced bacteria in culture. Using this approach, we show that
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common commensal Bacteroides species colonize IBD-susceptible and non-susceptible
hosts equivalently, but induce disease exclusively in susceptible animals. By contrast, we
show that commensal Enterobacteriaceae are strikingly enriched during spontaneous
disease, but a colitis-enriched Enterobacteriaceae isolate is not sufficient for disease
induction despite robust colonization. We thus identify distinct commensal bacterial
subsets with and without disease-inducing potential and show that their colitogenicity
would not have been predicted based on disease-associated alterations in colonization.

METHODS AND RESULTS
Development of non-gnotobiotic methods to screen for disease-inducing microbes in
antibiotic-pre-treated dnKO mice
We developed a system utilizing the dnKO model’s rapid disease onset and
exquisite antibiotic-responsiveness to screen commensal bacteria for colitis-inducing
potential. Since antibiotic treatment was highly effective in blocking disease in dnKO
mice (see Chapter 2), we hypothesized that mice pre-teated with antibiotics should
remain disease-free after treatment cessation if isolated from microbial exposures but
should develop disease if exposed to the microbiota of untreated mice. In initial
experiments, mice were housed in our specific-pathogen free barrier facility on the 7th
floor of the Clinical Sciences Research Building at Washington University. (Animal
protocols for this an all subsequent experiments were approved by Washington
University's animal studies committee.) In this facility, it is standard practice for
individual cage components (cage bottoms, cage lids, wire racks, water bottles, and feed)
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to be sterilized by autoclave or irradiation, stored in open air in the mouse facility, and
assembled as necessary for use. The disinfectant Clidox®-S (Pharmacal Research
Laboratories, Inc.) is used at a 1:18:1 concentration and each batch of disinfectant is used
for several days before a fresh batch is made. For our experiments, we disinfected our
hands and the exterior of all cages with Clidox®-S solution before handling mice. Cages
containing mice are opened only in hoods with HEPA-filtered air.
In initial experiments, dnKO mice were pre-treated with antibiotics for 10 days
with frequent transfer to freshly assembled cages and then removed from treatment. (All
experiments in Chapter 3 were performed using combined metronidazole + ciprofloxacin
treatment.) After treatment cessation, mice were either maintained in freshly assembled
cages (“isolated”, negative controls) or were co-housed with an untreated, non-dnKO
littermate mouse in a cage containing that mouse’s dirty bedding and were also smeared
with 2 mL per mouse of a suspension of intestinal contents harvested from an untreated
donor mouse and suspended in 10 mL of sterile PBS (Backhed, Ding et al. 2004). Mice
were sacrificed after 7 days and colons were analyzed for pathology. Antibiotic-pretreated dnKO mice (but not non-dnKO littermate controls) experimentally exposed to
intestinal contents developed severe colitis with ulceration and shortening of the colon,
but colons of isolated dnKO mice also showed some degree of mucosal thickening and
inflammation (Figure 3.1 and not shown). These results confirmed that our approach
could work in principle, but suggested that more stringent animal care practices would be
required to ensure precision and reproducibility.
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To enhance precision and reproducibility of mouse handling practices, we
modified several experimental parameters. Instead of conventional caging, we began
using “enhanced caging” that had been autoclaved after assembly and began rigorously
decontaminating all surfaces with a stronger 1:8:1 solution of Clidox®-S prepared fresh
daily. These techniques were previously used by the Virgin laboratory during discovery
of murine norovirus (Karst, Wobus et al. 2003). We performed all animal care personally
rather than allowing Division of Comparative Medicine technicians to handle the cages.
We also began using enhanced contact precautions, donning an extra pair of gloves and
isolation gown and changing these outer layers after handling mice or cages from each
experimental group. Additionally, we began pre-treating mice with antibiotics for ≥3
weeks instead of 10 days prior to treatment cessation to ensure that no residual antibioticsensitive organisms remained. These enhanced animal care practices proved highly
effective (see below).

Development of a standardized stock of intestinal contents
The human intestinal microbiota varies considerably from individual to individual
in terms of both the bacterial species present and their relative proportions (Turnbaugh,
Quince et al. 2010). We performed a qualitative experiment to examine microbiota
variability between mice. Age-matched, untreated male mice (non-dnKO genotypes)
were co-housed beginning at weaning (age 3 weeks). After ~3 weeks of co-housing, mice
were sacrificed on each of two successive days (2 mice per day). Cecal contents were
collected, pooled, serial diluted, and dilutions were cultured aerobically on chocolate
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agar. The striking day to day differences in relative frequency of different colony types
qualitatively illustrated that even in co-housed mice there was a high degree of
microbiota variability.
To establish a reproducible source of intestinal microbes for subsequent
experiments, we adapted an approach that was successfully employed in an experimental
model of intra-abdominal abscesses to characterize the pathogenic contributions of
various bacteria in a complex polymicrobial mixture and has also been used in
experiments with “humanized” gnotobiotic mice (Onderdonk, Weinstein et al. 1974;
Weinstein, Onderdonk et al. 1974; Turnbaugh, Ridaura et al. 2009). Ceca were harvested
from untreated non-dnKO mice from the dnKO colony and transferred to the anaerobic
chamber where contents were removed, suspended in sterile, pre-reduced PBS + 20%
glycerol, and frozen at -80°C in single-use aliquots in 1.8 mL CryoTube Vials (377267,
Nunc). Prior to freezing, an aliquot of the mixture was titered on non-selective anaerobic
and aerobic media. Subsequently, frozen aliquots were thawed, adjusted to the same
concentration of total cecal material, and titered on the same media types. We observed
some loss of viability in the frozen stock, with greater loss among total anaerobic bacteria
than aerobes (Table 3.1).

Sensitive, quantitative system to screen for disease-inducing microbes in antibioticpre-treated dnKO mice
Using the methodologic improvements described above, we validated our nongnotobiotic screening system for disease-inducing microbes in antibiotic-pre-treated
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dnKO mice. dnKO mice housed under enhanced animal care conditions (see above) were
pre-treated with antibiotics for ≥3 weeks with frequent transfers to fresh sterile cages to
eliminate residual antibiotic-sensitive bacteria from their environment. Two days after
treatment cessation, the mice were orogastrically gavaged with sterile PBS or freshly
thawed aliquots of intestinal contents from untreated animals (Table 3.1, Figure 3.3).
Mice gavaged with intestinal contents but not PBS developed severe disease that was
fatal in some cases (Figure 3.3). Examination of colons demonstrated that intestinal
contents induced severe colonic gross and microscopic pathology resembling that seen in
untreated, spontaneously colitic dnKO mice (Figures 3.4 to 3.6). Colitis induction was
significant by all quantitative metrics compared to PBS-gavaged controls, which did not
exhibit signs of colitis (Figure 3.4 to 3.6). Gavaging freshly harvested intestinal contents
produced similar outcomes as gavaging frozen material (not shown). These results
supported the hypothesis that colitis induction in dnKO mice was microbe-dependent,
suggested that freezing did not eliminate all colitigenic microorganisms, and
demonstrated the feasibility of our method as a sensitive and quantitative system to
screen bacteria for disease-inducing potential.

Colitis-inducing microbes can be grown in mixed cultures of cecal contents
Since certain members of the colonic microbiota cannot be cultured(Savage 1977;
Eckburg, Bik et al. 2005; Duncan, Louis et al. 2007), we conducted a proof-of-principle
experiment to assess whether we could culture colitigenic microorganisms. Intestinal
contents freshly harvested from untreated, non-dnKO donors were cultured anaerobically

55

on ANB agar for 48 hours or aerobically on chocolate agar for 24 hours. Cultures were
removed from culture plates using sterile swabs, suspended in sterile, pre-reduced PBS to
an optical density of 4 McFarland standards. Groups of antibiotic-pre-treated mice were
gavaged with sterile PBS, the aerobic culture alone, or a combination of the aerobic and
anaerobic cultures mixed in equal proportions. One mouse receiving the combination of
aerobic and anaerobic cultures lost >30% of maximum weight and was sacrificed 5 days
post-gavage; all others survived to the end of the three-week experiment. Neither survival
nor weight loss differed significantly between the two groups (p = 0.5220 and p = 0.4736;
Figure 3.7 A and C respectively). However we observed development of severe colitis in
mice gavaged with the combination of aerobic and anaerobic cultures that was significant
relative to both PBS gavage and to gavage of aerobic cultures alone (p < 0.01; Figures 3.7
B and 3.8). By contrast, gavage of aerobic culture alone did not induce significant disease
(p > 0.05; Figure 3.7 B). These results, which were remniscent of findings in gnotobiotic
HLA-B27 rats (Rath, Schultz et al. 2001), suggested that colitis-inducing bacteria could
be grown in culture, but aerobic or facultatively anaerobic bacteria were likely not
sufficient for disease induction.
This experiment also demonstrated dissociation between weight post-gavage and
intestinal pathology. Although short-term antibiotic treatment blocks pro-inflammatory
cytokine secretion and promotes weight gain in dnKO mice (Kang, Bloom et al. 2008),
we have observed that dnKO mice treated for longer periods exhibit sporadic, variable
weight loss despite remaining colitis-free (not show). Using weight as a disease metric
was also problematic due to the complex breeding scheme of compound heterozygotes
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used to produce dnKO mice, which ensured a constant scarcity of mice and therefore
necessitated using both males and females animals from multiple litters which were not
perfectly age-matched. Although neither age nor sex differences appeared to affect colitis
development, they naturally produced a degree of heterogeneity in weights. In all
subsequent experiments, we therefore relied on colon-specific metrics of colitis rather
than weight loss or serum cytokines to ensure results were not confounded by extraintestinal processes.

Techniques for isolation and identification of aerobic and anaerobic bacteria from
cecal mixed cultures
We established a system to isolate and identify intestinal bacteria. Single colonies
from mixed cultures were picked and sub-cultured on fresh media, after which a single
colony from the sub-culture was passaged to ensure purity. Genomic DNA was extracted
from individual isolates and the bacterial 16S rRNA gene was PCR-amplified using
primers Bact-8f and Bact-1510r (Eckburg, Bik et al. 2005; Gill, Pop et al. 2006). The
resulting PCR product was then sequenced using the original PCR primers. Sequences
were edited and trimmed for quality using the Trev 1.9 program of the Staden Package©.
Forward and reverse reads were assembled into a single contig using SeqMan from the
DNAStar© Lasergene software package, Version 8.0.2. The 16S sequences were
classified using the Ribosomal Database Project (RDP, Release 10, Update 15) Classifier
and the closest cultured and un-cultured matches from GenBank were identified using
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RDP’s SeqMatch program supplemented by BLAST analysis (Altschul, Gish et al. 1990;
Cole, Chai et al. 2007; Wang, Garrity et al. 2007; Cole, Wang et al. 2009).

Isolation of numerous, widely diverse bacteria from intestinal mixed cultures
We originally planned to isolate a variety of intestinal bacteria, identify them,
pool them by taxonomic group, and inoculate the pooled isolates into healthy dnKO mice
to test for colitigenicity. Commensal intestinal bacteria vary by several orders of
magnitude in their overall abundance within the intestinal microbiota (Dethlefsen, Huse
et al. 2008; Huse, Dethlefsen et al. 2008), presenting challenges for isolation of less
abundant bacteria. When intestinal contents are cultured on a single non-selective media
type, it is only possible to isolate relatively abundant bacteria because rarer organisms
will be missed in a mixed lawn of bacteria. We therefore employed a variety of selective
aerobic and anaerobic media for bacterial isolation to increase the range of bacteria we
could isolate (Figure 3.9). To further increase the sensitivity of our isolation methods, we
plated intestinal contents on these media types in serial, half-log dilutions, which allowed
us to isolate unique-appearing colonies from the plates with the largest number of
individually distinguishable colonies (Onderdonk, Weinstein et al. 1974; Sakon, Nagai et
al. 2008). We allowed cultures to incubate for 2-7 days (aerobic growth) or 7-14 days
(anaerobic growth), then picked unique-appearing isolates using the techniques described
above.
The method of serial dilutions on selective media allowed us to sample microbes
with abundances varying over an estimated 107-fold range (Figure 3.10 D). Despite the
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likely occurrence of some redundancy of isolates from each media type and extensive
redundancy between isolates from certain media types, the range of isolate titers suggests
the ability to widely sample the cultivable microbiota by this approach. We calculated
that sampling depth provided by culturing continues to be considerably greater than that
of culture-independent broad-range bacterial 16S rRNA gene sequencing in various
landmark studies (Figure 3.10 C) (Kroes, Lepp et al. 1999; Eckburg, Bik et al. 2005;
Dethlefsen, Huse et al. 2008; Turnbaugh, Hamady et al. 2008). Importantly, the presence
of rarer species detectable on some media types would not have been detected at the
sampling depth of any of the sequencing surveys. Approaches like mass sequencing
allow revolutionarily high-resolution of the taxonomy of abundant microbes within the
microbiota. However mass sequencing approaches accumulate data additively with
additional effort rather than exponentially, therefore our results results demonstrate that
culture-based approaches remain the most sensitive and specific technique for deep
sampling of cultivable bacteria within the intestinal microbiota.
We identified a subset of the isolates depicted in Figure 3.10 D by 16S rRNA
gene sequencing, revealing a widely diverse range of bacteria representing the four phyla
most commonly identified in culture-independent sequencing surveys of mammalian
intestinal microbiota: Firmicutes, Bacteroidetes, Proteobacteria, and Actinobacteria
(Figure 3.11). Interestingly, some of the isolated bacteria were apparently novel isolates
that have only previously been described by culture-independent methods. All identified
isolates grew on chocolate agar and/or anaerobic blood agar. Thus the pools of cultured
bacteria gavaged into dnKO mice in the experiments depicted in Figures 3.7 and 3.8 were
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presumably considerably more complex than the panel of bacteria depicted in Figure
3.11.

Intestinal contents cultured on media selective for Gram-negative obligate
anaerobes induce disease in IBD-susceptible hosts
Due to the large numbers and broad diversity of cultivable intestinal bacteria
(Figure 3.11), difficulty in growing many isolates in useful quantities, and limited
availability of dnKO mice for screening experiments, we determined that testing pools of
bacteria isolated from mixed cultures on general growth media would not be the most
efficient approach to screen for specific colitigenic bacteria. As an alternate approach, we
decided to first limit the complexity by screening mixed cultures of intestinal contents
containing more restricted pools of bacteria than those used in Figures 3.7 and 3.8. The
mammalian intestinal microbiota contains hundreds of bacterial species belonging
primarily to the phyla Bacteroidetes (Gram-negative obligate anaerobes) and Firmicutes
(Gram-positive, predominantly obligate anaerobes), with other phyla including
Proteobacteria (Gram-negative, predominantly facultative anaerobes) present at lower
abundance in healthy hosts (Backhed, Ley et al. 2005). However the most abundant
bacteria within the microbiota belong to a relatively restricted number of highly
represented taxa, primarily within the Bacteroidetes and Firmicutes phyla (Dethlefsen,
Huse et al. 2008). We hypothesized that disease would likely depend on the most
abundant members of the microbiota.
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We adopted two approaches to restrict complexity: growing mixed cultures
containing only abundant members of the microbiota and culturing on more selective
media types. Dilutions of frozen intestinal contents from untreated mice (described
above) were cultured in parallel on a variety of anaerobic culture media (Figure 3.12).
The mixed cultures were grown on non-selective media (ANB agar), media selective for
Gram-negative obligate anaerobes (LKV agar), or media inhibitory towards Gramnegative bacilli and enriched for growth of Gram-positive anaerobes (CNA agar). From
each media type, we harvested mixed cultures from a dilution at which ~1500 colonies
grew, ensuring the culture contained only relatively abundant (approximately ≥0.07%
abundance) intestinal bacterial cultivable on that media type (Table 3.2). We also
harvested a culture of concentrated intestinal contents grown anaerobically on ANB agar
and a concentrated culture grown aerobically on chocolate agar (Figure 3.12 and Table
3.2). Anaerobic cultures were harvested after 3 days of incubation using sterile swabs,
suspended in sterile pre-reduced PBS, and frozen at -80˚C in single-use aliquots with
20% pre-reduced glycerol. Aerobic cultures were harvested by the same method after 48
hours incubation (Table S1). The titer of each frozen stock was determined prior to use in
gavage experiments.
To test whether the restricted cultures could induce disease, we gavaged groups of
antibiotic-pre-treated dnKO mice with the anaerobic mixed cultures combined in 1:1 ratio
with the aerobic culture. Mice receiving diluted ANB and LKV cultures developed severe
intestinal pathology relative to PBS-gavaged controls while undiluted ANB culture
induced a non-significant trend towards disease induction (Figure 3.13). Mice gavaged
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with the CNA culture showed a trend towards development of milder disease that did not
significantly differ from PBS-gavaged controls. Quantitative histologic metrics of
inflammation confirmed significant disease induction by the diluted ANB and LKV
cultures. These results confirmed that colitis-inducing bacteria could be grown in culture
and suggested abundant Gram-negative obligate anaerobes might be sufficient for disease
induction.

Isolation and classification of abundant commensal bacteria cultivable on LKV agar
To isolate Gram-negative, anaerobic bacteria, freshly thawed aliquots of intestinal
contents (see above) were diluted to the concentration used in preparation of the LKV
mixed culture used for gavage (Table 3.2) and cultured anaerobically on LKV agar and
Bacteroides bile esculin (BBE) agar. Unique-appearing colonies were picked from plates,
sub-cultured on fresh media, and passaged to ensure purity. Isolates were identified by
sequencing the PCR-amplified 16S rRNA gene as described above; sequence identity
was determined by BLAST2 analysis. Unique bacterial species isolated from LKV agar
are listed in Table 3.3. For isolates <98% identical to the most similar type strain, the
most similar cultured isolate in the RDP database was also identified. All isolates from
BBE agar were redundant with bacteria isolated on LKV agar. All were >99% similar to
sequences identified in metagenomic sequencing of rodent commensal microbiota (not
shown).
As expected, the isolates were predominated by members of the phylum
Bacteroidetes from the genera Bacteroides and Parabacteroides (Table 3.3), which are
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Gram-negative obligate anaerobes belonging to the group known as the intestinal
Bacteroidales and are highly evolved to colonize the mammalian intestine (Coyne and
Comstock 2008). They include Bacteroides vulgatus, which has been implicated in colitis
induction in the gnotobiotic HLA-B27 transgenic rat model and the carrageenan-induced
colitis model in guinea pigs, but did not induce colitis when inoculated into germ-free IL10-/- mice (Onderdonk, Franklin et al. 1981; Onderdonk, Bronson et al. 1987; Sellon,
Tonkonogy et al. 1998; Rath, Wilson et al. 1999). Parabacteroides distasonis, a member
of the altered Schaedler Flora, may produce milder inflammation in gnotobiotic HLAB27 transgenic rats (Rath, Herfarth et al. 1996), but to our knowledge the other
Bacteroidetes isolates have not been implicated in IBD. One Bacteroides isolate is >99%
identical at the 16S rRNA gene level to a GenBank sequence of an unpublished isolate
identified as “Bacteroides sp. TP-5”. We are aware of no publications that have
characterized Bacteroides sp. TP-5, but the GenBank entry is titled “The Bacteroides
species is an important environmental risk factor for colon carcinogensis in T-cell
receptor b and p53 double-knockout mice” (Kado 2009). Other than Bacteroides sp. TP5, the most closely related isolate in the RDP database is only ~95% identical, suggesting
this isolate may represent a novel, largely uncharacterized Bacteroides species.
We also initially isolated two members of the phylum Proteobacteria, class
Betaproteobacteria, order Burkholderiales (Wang, Garrity et al. 2007). The isolates were
<97% identical to each other and ~94-96% identical to the most closely related isolate in
the RDP database, a recently described gram-negative strict anaerobe with the proposed
name Parasutterella excrementihominis gen. nov., sp. nov. that is proposed to represent a
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novel genus and species (Nagai, Morotomi et al. 2009). Each of these Proteobacteria
isolates thus represented a potentially novel species, although as noted they have been
previously detected in metagenomic sequencing of commensal microbiota. We are aware
of no publications specifically examining either isolate’s interactions with its host.
However, as was reported for P. excrementihominis, both isolates proved extraordinarily
difficult to culture in usable quantities (Nagai, Morotomi et al. 2009) and the isolates
ultimately lost viability. These bacteria were therefore not characterized in subsequent
experiments.
We also isolated Lactobacillus murinus, which is a gram-positive,
microaerophilic commensal commonly found throughout the murine gastrointestinal tract
and is a member of the altered Schaedler flora (Dewhirst, Chien et al. 1999; SarmaRupavtarm, Ge et al. 2004). A study of lactobacilli in murine colitis identified L. murinus
in non-colitic animals but failed to detect it in IL-10 deficient colitic mice (Pena, Li et al.
2004). We did not characterize L. murinus in subsequent experiments because lactobacilli
are known to be highly metronidazole-resistant (Hammad and Shimamoto 2010) and can
be commonly isolated from the fecal microbiota of non-colitic dnKO mice treated with
metronidazole and ciprofloxacin combination therapy (not shown)

Commensal Bacteroides isolates induce disease in IBD-susceptible but not nonsusceptible hosts
We screened five of the Bacteroidetes isolates listed in Table 3.3 for colitisinducing potential by gavaging pure cultures of each into antibiotic-pre-treated mice. For
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preparation of gavage inocula, 24-hour cultures of the respective isolate were grown
anaerobically in standing culture in TYG broth (Goodman, McNulty et al. 2009). Each
culture was concentrated by centrifugation, mixed with sterile, pre-reduced PBS +
glycerol to a final concentration of 20% glycerol, and frozen at -80°C in single-use
aliquots. Titers of each frozen stock were determined prior to use in gavage. To perform
colonization experiments, aliquots were thawed in a 37°C water bath, transferred to the
anaerobic chamber, volume-adjusted in sterile pre-reduced PBS, and immediately
transported to the mouse facility for orogastric gavage (Goodman, McNulty et al. 2009).
Gavage doses were confirmed by back-titering the inocula. For sterile PBS gavage, we
added sterile, pre-reduced glycerol to a concentration equivalent to that in the thawed
bacterial gavage inocula.
We found that pure cultures of each of the Bacteroidetes isolates induced colitis in
dnKO mice to varying degrees (Figure 3.15 and 3.16). Unexpectedly, an isolate of
Bacteroides thetaiotaomicron, a well-characterized symbiotic species (Goodman,
McNulty et al. 2009), potently induced colitis in dnKO mice. As expected, this isolate
was innocuous in Il10r2+/- control animals, which did not differ from PBS-gavaged
controls (Figures 3.16 to 3.19). These results demonstrated the induction of disease by
commensal Bacteroides in a host-genotype-specific fashion.
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Antibiotic treatment eliminates cultivable intestinal Bacteroides from the fecal
microbiota
Given the ability of commensal Bacteroides species to induce disease in dnKO
mice, we hypothesized that these bacteria must be eliminated from the microbiota by
antibiotic treatment. We tested this hypothesis by culturing fecal bacteria on selective and
non-selective culture media. Fecal samples from 4-week-old untreated dnKO mice or
dnKO mice treated with antibiotics for ≥3 weeks were collected in sterile microcentrifuge
tubes. Samples were immediately placed on ice, weighed, transferred to an anaerobic
chamber within ≤1 hr of collection, suspended in 500 µl of sterile pre-reduced PBS by
repeated vigorous vortexing and disruption with a sterile pipette tip, and titered by
culturing 10-fold serial dilutions in parallel on ANB agar (non-selective, general
anaerobic growth media) or Bacteroides bile esculin (BBE) agar, which is selective and
differential media for the isolation of intestinal Bacteroides species (Livingston, Kominos
et al. 1978). 10 µl of each dilution was spotted in triplicate on quadrants of titer plates.
BBE titers were counted after 48 hours and ANB titers were counted at 48 hours and
confirmed after 5 days. Fecal titers were calculated as cfu/g of feces.
Using these methods, we confirmed that antibiotic treatment eradicated cultivable,
disease-inducing intestinal Bacteroides from the fecal microbiota. Fecal samples from
antibiotic-treated dnKO mice exhibited no bacterial growth when quantitatively cultured
on Bacteroides bile esculin (BBE) agar at a detection limit of 17 colony-forming units
(cfu) per sample (Figure 3.20). By contrast, we observed high bacterial titers (~109 cfu/g
of feces) on BBE agar in samples from untreated animals. Fecal titers on non-selective
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media did not differ between groups, confirming that antibiotics prevented disease by
selectively altering microbiota composition rather than by sterilizing the gut (Figure
3.20).

Gavaged Bacteroides species stably colonize antibiotic-pre-treated mice at high
levels regardless of host genotype
We reasoned that BBE agar could thus be used to assess Bacteroides colonization
of gavaged, antibiotic-pre-treated mice. Three of the Bacteroides isolates screened in
Figure 3.15 (B. thetaiotaomicron, B. vulgatus, and Bacteroides sp. TP5, see Table 3.3)
grew robustly by 48 hours in anaerobic culture on BBE agar (Figure 3.21 A). B. vulgatus
forms non-pigmented, circular, convex colonies with entire edges that are 1-2 cm in
diameter after 48 hrs growth. B. thetaiotaomicron forms colonies that are similar in size
and morphology to B. vulgatus but strongly pigmented. Bacteroides sp. TP5 forms
circular, convex colonies with entire edges that are 0.25-1 cm in diameter and nonpigmented or very lightly pigmented after 48 hrs.
Remarkably, we could thus monitor Bacteroides colonization by performing
serial, quantitative, specific fecal cultures on BBE agar. Antibiotic-pre-treated mice
gavaged with PBS remained free of cultivable Bacteroides, confirming absence of cageto-cage microbial contamination (Figure 3.22 A). By contrast, mice given pure cultures
of B. thetaiotaomicron, B. vulgatus, or Bacteroides species TP5 became stably colonized
at ~1010 cfu/g of feces (Figure 3.22). Bacterial identity was determined based on
characteristic colony size, morphology, and pigmentation pattern on BBE agar (Figure
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3.21 B) and confirmed by 16S rRNA gene sequencing of representative colonies.
Colonization levels were surprisingly high and consistent. Analysis of titers compiled
from animals of various genotypes from many experiments over multiple timepoints
revealed that they were normally distributed over an extremely narrow range (Figure
3.23). Antibiotic-pre-treated Il10r2+/- and dnKO mice became stably colonized with the
gavaged bacteria at equivalent levels (Figure 3.22), demonstrating that genotypedependent differences in disease induction were likely due to differences in host response
rather than altered colonization susceptibility.

Commensal Enterobacteriaceae but not Bacteroides are strikingly enriched in the
microbiota during spontaneous disease
Despite our finding that commensal Bacteroides induced disease in dnKO mice,
studies of the intestinal microbiota in IBD have not found Bacteroides to be consistently
enriched during disease (Onderdonk, Richardson et al. 1998; Frank, St Amand et al.
2007; Ott, Plamondon et al. 2008; Sokol, Pigneur et al. 2008; Takaishi, Matsuki et al.
2008; Frank, Robertson et al. 2010). We likewise observed that fecal titers on
Bacteroides bile esculin agar from untreated dnKO (spontaneously colitic) and Il10r2+/(non-colitic) mice did not significantly differ in either absolute levels or as a proportion
of total cultivable bacteria (Figure 3.24). By contrast, many studies have documented
IBD-associated enrichment of Enterobacteriaceae, Gram-negative, facultative anaerobes
(including the species E. coli) from the phylum Proteobacteria that can be selectively
cultured on MacConkey agar (Burke 1997; Onderdonk, Richardson et al. 1998; Frank, St
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Amand et al. 2007; Lupp, Robertson et al. 2007; Sartor 2008; Frank, Robertson et al.
2010; Strober 2010). In agreement with findings from other colitis models, we observed
that commensal Enterobacteriaceae were strikingly enriched in spontaneous disease,
accounting for ~50% of total cultivable fecal bacteria in untreated dnKO mice compared
with <0.5% of cultivable bacteria in co-housed Il10r2+/- controls (Figure 3.24).

Commensal Enterobacteriaceae are not sufficient for disease induction
The observation that Enterobacteriaceae are often elevated in IBD has led to
suggestions that these bacteria may play a pathogenic role in disease (Burke 1997;
Onderdonk, Richardson et al. 1998; Frank, St Amand et al. 2007; Edwards, Lucas et al.
2010). However it is unclear whether Enterobacteriaceae enrichment is a cause or effect
of disease since enrichment also occurs during non-IBD intestinal inflammation
experimentally induced by chemicals or microbial pathogens (Heimesaat, Bereswill et al.
2006; Heimesaat, Fischer et al. 2007; Lupp, Robertson et al. 2007; Stecher, Robbiani et
al. 2007; Sartor 2008). Importantly, commensal Enterobacteriaceae were eliminated from
antibiotic-treated mice (Figure 3.24 C), allowing us to directly test whether they could
induce disease. We isolated an Enterobacteriaceae species that was highly enriched in the
feces of an untreated, colitic dnKO mouse (~33% of total cultivable bacteria) and
identified it as Escherichia coli based on 16S rRNA sequence similarity to the closest
culture isolate (Figure 3.25). Confirmation of this species identification by phenotypic
identification using the API 20E strip (biocode 5144532, bioMerieux, Inc., Durham, NC)
in the Barnes-Jewish Hospital Medical Microbiology Laboratory confirmed this

69

classification. The isolate was maintained aerobically on MacConkey agar, ANB agar, or
in Trypticase Soy Broth.
To test the isolate’s disease-inducing potential, we gavaged it into antibiotic-pretreated dnKO mice. For preparation of the gavage inoculum, 16-hour cultures of E. coli
were grown in Trypticase Soy Broth in a 37°C shaker at 225 rpm. Each culture was
concentrated by centrifugation, mixed with sterile, pre-reduced PBS + glycerol to a final
concentration of 20% glycerol, and frozen at -80°C in single-use aliquots. The stock was
tittered prior to use in experiments. Other groups of dnKO mice were gavaged with B.
thetaiotaomicron or sterile PBS as positive and negative controls.

We quantified

bacterial colonization by performing parallel, serial fecal titers on BBE and MacConkey
agar (Figure 3.26). MacConkey titers were performed as for BBE titers (see above) and
were counted after 12-16 hours and confirmed for negative growth at 48 hours. E. coli
stably colonized antibiotic-pre-treated animals at consistent levels even higher than those
observed in untreated dnKO mice (compare Figure 3.24 C and 3.26 B) and comparable to
E. coli colonization levels in mono-associated gnotobiotic mice (Hapfelmeier, Lawson et
al. 2010). However E. coli did not induce significant disease relative to PBS, whereas B.
thetaiotaomicron induced significant disease relative to both E. coli and PBS by most
metrics (Figure 3.27 and 3.28).

DISCUSSION
The precise role of the intestinal microbiota in IBD induction remains an area of
active investigation (Sartor 2008; Strober 2010). Multiple theories exist concerning
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whether IBD can be induced by specific commensal microbes and, if so, whether the
disease-inducing microbes can be identified based on enrichment in the microbiota
during disease (Xavier and Podolsky 2007; Takaishi, Matsuki et al. 2008; Packey and
Sartor 2009; Cerf-Bensussan and Gaboriau-Routhiau 2010; Garrett, Gordon et al. 2010).
We previously hypothesized that disease in the dnKO mouse model (which bears genetic
defects in pathways linked to IBD in humans and which develops spontaneous, rapidonset, antibiotic-responsive colitis closely resembling human ulcerative colitis) depends
on a subset of commensal bacteria, likely obligate anaerobes, which are eliminated by
antibiotic treatment (Chapter 2). Here we fulfilled Koch's postulates for commensal
Bacteroides species in host-genotype-specific fashion using non-gnotobiotic methods in
dnKO mice. We found that Bacteroides species:
1)

were common to susceptible and non-susceptible hosts and were eliminated by
disease-blocking antibiotics,

2)

could be isolated and grown in pure culture,

3)

induced colitis when administered to antibiotic-pre-treated susceptible hosts but not
when administered to non-susceptible hosts, and

4)

could be quantitatively re-isolated from experimentally colonized animals at
equivalent levels regardless of host genotype.

The disparity in Bacteroides-induced disease thus appears to be attributable to differences
in host response rather than altered colonization susceptibility. We further showed that
commensal Enterobacteriaceae were strikingly enriched during spontaneous disease but a
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colitis-enriched E. coli isolate was not sufficient for disease induction despite robust
colonization.
Intriguingly, our results in dnKO mice, which bear medically relevant deficiencies
in the IL-10 receptor (Glocker, Kotlarz et al. 2009) and in TGFβ signaling (Franke,
McGovern et al. 2010), independently replicate findings from the medically relevant
HLA-B27 transgenic rat model (Hammer, Maika et al. 1990). Conventionally raised
transgenic rats develop spontaneous colitis characterized by striking enrichment of
commensal Enterobacteriaceae and unchanged levels of commensal Bacteroides
(Onderdonk, Richardson et al. 1998) However colonization of gnotobiotic transgenic rats
with the Bacteroides species B. vulgatus (and possibly Parabacteroides distasonis)
induced disease whereas colonization with a variety of IBD-enriched human isolates
including E. coli, a species of Enterobacteriaceae, did not (Rath, Herfarth et al. 1996;
Rath, Wilson et al. 1999). The HLA-B27 allele in humans is strongly linked to
spondyloarthritis (a collection of rheumatologic diseases that frequently includes IBD)
but is not an independent risk factor for IBD that is not associated with spondyloarthritis
(Brakenhoff, Heijde et al. 2010) It has thus been unclear whether findings in HLA-B27
transgenic rats would be more broadly relevant to IBD in general. However there are
intriguing similarities between the transgenic rat model and dnKO mice. Colitis in HLAB27 transgenic rats is T-cell-dependent (Hoentjen, Tonkonogy et al. 2006; Hoentjen,
Tonkonogy et al. 2007) and there is evidence that disease may be related to impaired
inhibition of T-cell activation by IL-10 and TGFβ through unknown mechanisms (Qian,
Tonkonogy et al. 2008). Similarly, we previously showed that adoptive transfer of dnKO
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CD4 T-cells into Rag-/- recipient mice induces fulminant colitis relative to transfer of
wild-type T-cells (Kang, Bloom et al. 2008). We and others have shown that transfer of
Il10r2-/- CD4 T-cells also induces enhanced disease, although to a lesser extent (Kang,
Bloom et al. 2008; Murai, Turovskaya et al. 2009).
B. vulgatus colonization was also pro-colitic in the gnotobiotic guinea pig model
of carrageenan-induced colitis, the model in which it was originally identified as a
potential colitogen (Onderdonk, Franklin et al. 1981; Onderdonk 2005). However B.
vulgatus mono-association did not induce disease in gnotobiotic Il10-/- mice and may
actually have been protective in gnotobiotic Il2-/- mice, whereas some commensal E. coli
species had pro-colitic effects in these models (Sellon, Tonkonogy et al. 1998; Kim,
Tonkonogy et al. 2005). Alleles of the gene for IL-10 and a component of the IL-2
receptor complex were found to be associated with IBD in recent genome-wide
association studies (Franke, Balschun et al. 2008; Franke, McGovern et al. 2010).
Reasons for the apparent disparity between these mouse models and the dnKO mouse and
HLA-B27 rat models are unclear. A recent study of intestinal biopsy material from
human patients found that Bacteroides thetaiotaomicron induced strong IL-8 secretion ex
vivo in tissue from IBD patients but not in tissue from healthy controls, whereas there
was no difference in IL-8 response between the two groups of tissues upon exposure to
an E. coli species (Edwards, Lucas et al. 2010). Much further work is needed, particularly
from human studies, but we believe in aggregate this evidence supports the idea that
commensal Bacteroides species may have specific colitogenic effects in at least a subset
of human IBD.
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Many studies have documented IBD-associated enrichment or depletion of
specific commensal bacterial subsets but it remains an important unresolved question
whether and how these alterations contribute to disease pathogenesis (Burke 1997; Frank,
St Amand et al. 2007; Takaishi, Matsuki et al. 2008; Packey and Sartor 2009; Peterson,
Garges et al. 2009; Frank, Robertson et al. 2010; Strober 2010). Our demonstration that
commensal Enterobacteriaceae were enriched during spontaneous disease but were not
sufficient for disease induction adds to a growing body of evidence that intestinal
inflammation provides both commensal and enteropathogenic Enterobacteriaceae with a
selective colonization advantage regardless of inflammation etiology (Onderdonk,
Richardson et al. 1998; Heimesaat, Bereswill et al. 2006; Lupp, Robertson et al. 2007;
Stecher, Robbiani et al. 2007; Ackermann, Stecher et al. 2008; Winter, Thiennimitr et al.
2010). Interestingly, disease-associated enrichment of Proteobacteria relative to
Bacteroidetes has also been observed in the lung microbiota of patients with asthma, a
chronic inflammatory disease (Hilty, Burke et al. 2010), and in the gastric microbiota of
patients infected with Helicobacter pylori, a cause of chronic atrophic gastritis
(Maldonado-Contreras, Goldfarb et al. 2010). In ecological terms, Enterobacteriaceae
thus appear to behave as invasive species capable of exploiting new niches created by
inflammation-induced ecosystem instability at mucosal surfaces. The Enterobacteriaceae
pathogen Salmonella typhimurium directly exploits intestinal inflammation by using
tetrathionate – a compound generated in the intestinal lumen in presence of host-derived
reactive oxygen species – as a respiratory electron acceptor to outcompete the
fermentative anaerobes that normally dominate the microbiota (Winter, Thiennimitr et al.
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2010). We speculate that similar mechanisms for exploiting inflammation could account
for “bystander enrichment” of commensal Enterobacteriaceae in IBD and may even be
related to the frequency with which non-pathogenic Enterobacteriaceae strains have
independently and convergently evolved pathogenic phenotypes (Pupo, Karaolis et al.
1997; Wirth, Falush et al. 2006). Thus, although disease-enriched bacteria may play
colitogenic roles in certain circumstances and disease-depleted bacteria may have anticolitic effects in others (Burke 1997; Sokol, Pigneur et al. 2008), our findings emphasize
that IBD-associated shifts in colonization are not a sufficient basis to form conclusions
about a microbe's effects on disease without additional evidence.
In this study, we have endeavored to address two key questions about IBD using
dnKO mice: (1) is disease induced by specific subsets of commensal microbes and, if so,
(2) can these subsets be identified based on disease-associated alterations in levels of
colonization? Our work provides evidence supporting the concept of commensal
specificity and disputing the concept that disease-associated enrichment necessarily
implies a causative role. These findings also underscore the importance of examining
microbial influences on pathogenesis in the context of host genetic predisposition
(Cadwell, Patel et al. 2010). The possibility that a microbe's colonization dynamics in
disease may be dissociable from its disease-inducing potential presents significant
obstacles for elucidating underlying microbial etiology. Mazmanian and colleagues
recently coined the term "pathobiont" to describe commensal or symbiotic microbes that
induce disease only in certain genetic or environmental contexts (Mazmanian, Round et
al. 2008; Chow and Mazmanian 2010), but no established criteria exist for classifying a
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microbe as a pathobiont or distinguishing pathobionts from conventional pathogens. We
propose refining the definition to state that unlike parasitic or opportunistic pathogens,
true pathobionts colonize at equivalent levels regardless of disease induction. Formal
demonstration that a microbe acts as a pathobiont would thus require fulfillment of hostgenotype-specific (or environment-specific) Koch's postulates resembling those described
here. Extending this concept, we note that it is even possible to envision a scenario in
which pathobiotic bacteria induce a targeted immunopathologic response that leads them
to become depleted within the microbiota despite playing a causative role in disease.
In summary, our results provide important insights into the intestinal microbiota's
role in IBD induction and suggest a candidate group of organisms that may be relevant to
disease induction in a subset of human cases. As new spontaneous animal models of IBD
based on other human susceptibility mutations become available, we propose that the
methods, experimental criteria and conceptual framework we develop here will allow
characterization of microbial contributions to disease in additional genetic contexts.
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Figure 3.1: Co-housing and exposure to intestinal contents from untreated control
mice induces disease in antibiotic-pre-treated dnKO mice.
3 week old dnKO mice housed in conventional cages were pre-treated with antibiotics
(metronidazole + ciprofloxacin) for 10 days, then antibiotics were halted and mice were
either maintained without experimental microbial exposures or co-housed with an
untreated non-dnKO mouse and smeared with intestinal contents from an untreated, nondnKO mouse. Mice were sacrificed and colons were analyzed for gross pathology after 7
days. Colons of mice experimentally exposed to intestinal contents exhibit severe
pathology with ulceration and shortening, but colons of isolated mice also show signs of
mucosal thickening and inflammation. Representative of 2-3 experiments per group with
1-2 mice per experiment.
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Figure 3.2: Bacterial composition of intestinal contents is highly variable from
sample to sample.
Intestinal contents from age-matched, untreated male mice (non-dnKO genotypes) cohoused for ~3 weeks beginning at weaning were harvested on each of two successive
days (2 mice per day). Serial dilutions of intestinal contents were cultured aerobically on
chocolate agar. Culture plates with similar numbers of cfu (inset labels) from each culture
day are shown. Note the highly variable morphology of abundant bacterial colonies
between the two samples.
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Figure 3.3: Gavaged intestinal contents from untreated donors induce fulminant
disease in antibiotic-pre-treated dnKO mice.
(A) Experimental timeline. Antibiotic treatment (metronidazole + ciprofloxacin) began at
weaning; mice housed were antibiotic-treated for ≥3 weeks and orogastrically gavaged
with experimental inocula 2 days after treatment cessation (Abx = antibiotics). Individual
mice were sacrificed after 21 days or when their weight reached ≤ 70% of maximal
weight.
(B) Antibiotic-pre-treated dnKO mice housed in enhanced caging under stringent cagecare precautions were gavaged with PBS (n = 4 mice) or a freshly thawed aliquot of
pooled intestinal contents from untreated non-dnKO donors that had been frozen in 20%
glycerol at -80°C under anaerobic conditions (n = 6 mice). The gavage dose of intestinal
contents was 2x107 total cfu per mouse, titered on Anaerobic Reducible Blood (ANB)
Agar. Mice were sacrificed at 3 weeks post-inoculation or upon loss of >30% of
maximum body weight. Survival analyzed by Kaplan-Meier method, and statistical
significance determined by the log-rank test. Results are representative of multiple
independent experiments. All statistical analysis was performed using Prism v3.02
(GraphPad Software) unless otherwise indicated.
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Figure 3.4: Gavaged intestinal contents from untreated donors induce severe colonic
gross pathology in antibiotic-pre-treated dnKO mice.
Pathology scores of antibiotic-pre-treated dnKO mice gavaged with sterile PBS or
intestinal contents from untreated donors as described in Figure 3.3, displayed as
individual (symbols) and median (bars) scores. Statistical significance determined by
Mann-Whitney U-test using SPSS 16.0 (SPSS Inc.) due to a problem with Prism's
algorithm.
(A) Cecum pathology scores.
(B) Transverse colon pathology scores.
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Figure 3.5: Gavaged intestinal contents from untreated donors induce severe colitis
in antibiotic-pre-treated dnKO mice.
Representative images of H&E stained rectal histology of antibiotic-pre-treated dnKO
mice gavaged with sterile PBS or intestinal contents from untreated donors as described
in Figure 3.3. Bar = 100 µm.
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Figure 3.6: Gavaged intestinal contents from untreated donors induce severe colonic
gross pathology in antibiotic-pre-treated dnKO mice.
Quantitative histologic disease metrics of antibiotic-pre-treated dnKO mice gavaged with
sterile PBS or intestinal contents from untreated donors as described in Figure 3.3,
displayed as mean +/- SEM. Statistical significance determined by unpaired t-test.
(A) Transverse colon crypt height.
(B) Transverse colon crypt width.
(C) Rectum crypt height.
(D) Rectum crypt width.
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Figure 3.7: Combined aerobic and anaerobic bacterial cultures of intestinal contents
induce non-fatal colitis in antibiotic-pre-treated dnKO mice, but mixed aerobic
culture alone does not.
Intestinal contents from untreated donors were cultured anaerobically on ANB agar or
aerobically on chocolate agar. Cultures were suspended in sterile, pre-reduced PBS at an
optical density of 4 McFarland standards. Antibiotic-pre-treated dnKO mice were
gavaged with sterile PBS, with the aerobic culture alone, or with a combination of the
aerobic and anaerobic cultures mixed in equal proportions.
(A) One mouse receiving the mixed aerobic and anaerobic cultures was sacrificed 5 days
post-gavage due to loss of >30% of maximum weight. All other mice were sacrificed 3
weeks post-gavage. Kaplan-Meier survival analysis; groups are not significantly different
by log-rank test: p = 0.5220.
(B) Cecum pathology scores of mice in (A). Statistical significance determined by the
Kruskal-Wallis test with post-hoc Dunn’s test: H 2 = 18.21, p = 0.0001. All significant
pairwise comparisons are displayed: **, p < 0.01.
(C) Weight change post-gavage of mice in (A). Groups are not statistically significant by
1-way ANOVA: F 2,20 = 0.7760, p = 0.4736.
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Figure 3.8: Representative cecal pathology of antibiotic-pre-treated dnKO mice
gavaged with aerobic and anaerobic bacterial cultures of intestinal contents.
Representative cecal whole mounts of antibiotic-pre-treated dnKO mice described in
figure 3.7. Righthand images are magnified views of images on left (inset areas indicated
by boxes).
(A) Mouse gavaged with PBS.
(B) Mouse gavaged with aerobic culture of intestinal contents.
(C) Mouse gavaged with combined aerobic and anaerobic culture of intestinal contents.
Arrows indicate ulcers.
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Figure 3.9: Cultivation of intestinal contents on selective culture media for bacterial
isolation.
Intestinal contents from untreated, wild-type mice were harvested, suspended in sterile,
pre-reduced PBS, serially diluted, and cultured on a variety of aerobic and anaerobic nonselective and selective media. The media types used for anaerobic culture were
Anaerobic Reducible Blood Agar (“ANB”, Remel, general anaerobic growth media),
Anaerobic Reducible CNA Blood Agar (“ACNA”, Remel, enriched for growth of Gram
positive anaerobic organisms), Anaerobic Reducible LKV Blood Agar (“LKV”, Remel,
selective for growth of Gram negative obligate anaerobes), Bacteroides fragilis Isolation
Agar (“BBE”, Remel, contains gentamicin to inhibit most facultative anaerobes, bile to
inhibit most anaerobic gram negative bacteria, and esculin to differentiate members of the
B. fragilis group), and Rogosa agar (“Rog”, for cultivation of lactobacilli). The media
types used for aerobic culture were Tryptic Soy Agar with 5% Sheep Blood (“TSA”,
Remel, general aerobic growth media), Chocolate Agar (“Choc”, Remel, general aerobic
growth media enriched for isolation of fastidious aerobes), Columbia CNA with 5%
Sheep Blood (“CCNA”, Remel, for selective isolation of gram-positive cocci and
inhibition of gram-negative bacilli), bile esculin azide agar (“BEA”, Remel, aerobic
media for isolation of enterococci), and MacConkey Agar (“Mac”, selective and
differential for isolation of gram negative aerobes or facultative anaerobes).
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Figure 3.10: Plating serial dilutions of intestinal contents on selective media allows
deep sampling of the intestinal microbiota.
(A) Culture media from Figure 3.9 labeled to indicate the approximate limits of detection
in terms of total cultivable intestinal bacterial load (cfu/g of intestinal contents) at various
dilution cutoffs. Limits of detection represent the approximate titer within intestinal
contents that a species would need in order to be detected at the corresponding dilution
cutoff.
(B) Approximate numbers of total cfu detected on ANB agar (general, non-selective
anaerobic media) at each dilution cutoff. Color-coded as in (A).
(C) Average sampling depths of various landmark microbiota surveys performed by 16S
rRNA sequencing using either the Sanger methods or 454 method (Kroes, Lepp et al.
1999; Eckburg, Bik et al. 2005; Dethlefsen, Huse et al. 2008; Turnbaugh, Hamady et al.
2008). Surveys are color-coded as in (A) and (B) to indicate the corresponding dilution
cutoff surpassed. Note the presence of colony types on some media that would not have
been detected at the sampling depth of any of the sequencing surveys.
(D) Estimated titers of a panel of bacterial isolates picked from the plates in (A). Isolates
picked based on unique-appearing colony morphology, with titers estimated by number
of similar-appearing colonies on the same media type. By this method, some degree of
redundancy within each media type and redundancy between certain media types should
be assumed.
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Figure 3.11: Diversity of bacterial isolates from selective media (subset).
A subset of isolates isolated anaerobically from ANB agar, anaerobic reducible CNA
blood agar, or LKV agar or aerobically from chocolate agar were classified according to
16S rRNA gene sequence using the Classifier and SeqMatch function of the Ribosomal
Database Project (RDP, Release 10, Update 15). A phylogenetic tree was constructed
using the RDP Treebuilder application with an archaeal 16S sequence as the outgroup.
Taxonomic assignments to the genus or family level by the RDP Classifier are listed in
the figure key.
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Figure 3.12: Preparation of selective mixed cultures of intestinal contents for
gavage.
An aliquot of frozen intestinal contents (see Figure 3.3 and Table 3.1) was thawed,
serially diluted, and cultured anaerobically on the indicated media types. 3-day mixed
cultures were harvested from the indicated culture plates (in squares) and frozen in 20%
glycerol (See Table 3.2). Titer of the frozen stocks was determined prior to use in
experiments. For gavage, aliquots of each culture were subsequently thawed and adjusted
to desired doses for gavage.
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Figure 3.13: Selective mixed cultures of intestinal contents induce intestinal gross
pathology in antibiotic-pre-treated dnKO mice.
Pathology scores of intestines from antibiotic-pre-treated dnKO mice gavaged with sterile
PBS or with the indicated anaerobic mixed cultures of intestinal contents mixed 1:1 with
aerobic cultures grown on chocolate agar at 0 dilution (see Figure 3.12 and Table 3.2).
Individual (symbols) and median (bars) pathology scores are displayed. Gavage doses:
ANB -1 = 6.6x107 total cfu/mouse; ANB -4.5 = 6.4x107 total cfu/mouse; LKV -4 =
7.3x107 total cfu/mouse; CNA -4.5 = 5.4x107 total cfu/mouse. Statistical significance
relative to PBS determined by Dunn's multiple comparison test: n.s., p > 0.05; *, p <
0.05; **, p < 0.01. The screen was unrepeated.
(A) Cecum gross pathology scores.
(B) Transverse colon pathology scores.
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Figure 3.14: Selective mixed cultures of intestinal contents induce mucosal
inflammation in antibiotic-pre-treated dnKO mice.
Quantitative histologic disease metrics of intestines from antibiotic-pre-treated dnKO
mice gavaged with sterile PBS or with selective mixed cultures of intestinal contents as
described in Figure 3.13. displayed as mean +/- SEM. Statistical significance relative to
PBS determined by Dunnett's multiple comparison test: n.s., p > 0.05; *, p < 0.05.
(A) Transverse colon crypt heights.
(B) Rectum crypt heights.
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Figure 3.15: Pure cultures of diverse commensal intestinal Bacteroidetes isolates
induce intestinal pathology in antibiotic-pre-treated dnKO mice.
Screen for colitis induction by Bacteroidetes isolates. Cecum gross pathology scores of
antibiotic-pre-treated dnKO mice gavaged with 1x108 cfu/mouse of pure cultures of the
indicated primary bacterial isolates (see Table 3.3). Unrepeated for B. uniformis and P.
goldsteinii.
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Figure 3.16: Pure cultures of diverse commensal intestinal Bacteroidetes isolates
induce colitis in antibiotic-pre-treated dnKO mice.
Representative H&E stained cecal histology of antibiotic-pre-treated dnKO mice gavaged
with Bacteroides species as described in Figure 3.15. A non-inflamed cecum from an
antibiotic-pre-treated B. thetaiotaomicron-gavaged Il10r2+/- control mouse is shown for
comparison. Scale bar = 200 µm.
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Figure 3.17: Bacteroides thetaiotaomicron induces pathology in antibiotic-pretreated dnKO but not Il10r2+/- mice.
Pathology scores of antibiotic-pre-treated mice of the indicated genotypes gavaged with
PBS or a pure culture of the B. thetaiotaomicron isolate described in Table 3.3 (7x107
cfu/mouse). Statistical significance determined by Kruskal-Wallis test with post-hoc
Dunn’s test. All significant pairwise comparisons are displayed: *, p < 0.05.
(A) Cecum pathology scores: H 2 = 12.26, p = 0.0022.
(B) Transverse colon pathology scores: H 2 = 11.36, p = 0.0034.
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Figure 3.18: Bacteroides thetaiotaomicron induces colitis in antibiotic-pre-treated
dnKO but not Il10r2+/- mice.
Representative H&E stained rectal histology of antibiotic-pre-treated mice gavaged with
PBS or a pure culture of B. thetaiotaomicron as described in Figure 3.17. Scale bar = 50
µm.
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Figure 3.19: Quantification of Bacteroides thetaiotaomicron-induced colitis in
antibiotic-pre-treated dnKO mice.
Quantitative histologic disease metrics of intestines from mice described in Figures 3.17
and 3.18 displayed as mean +/- SEM. Statistical significance determined by 1-way
ANOVA with post-hoc Tukey’s test. All significant pairwise comparisons are displayed
if the omnibus p-value by ANOVA was significant: *, p < 0.05; **, p < 0.01.
(A) Transverse colon crypt height: F 2,10 = 8.596, p = 0.0067.
(B) Rectum crypt height: F 2,10 = 12.55, p = 0.0019.
(C) Transverse colon crypt width: F 2,10 = 2.057, p = 0.1786.
(D) Rectum crypt width: F 2,10 = 12.05, p = 0.0022.
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Figure 3.20: Antibiotic treatment eliminates cultivable intestinal Bacteroides from
the intestinal microbiota.
Fecal samples from 4-week old untreated dnKO mice or from dnKO mice treated with
antibiotics (metronidazole + ciprofloxacin) for ≥3 weeks were titered in parallel
anaerobically on non-selective (ANB) agar and Bacteroides bile esculin (BBE) agar.
Titers from individual mice (symbols) and means of log 10 -transformed titers (bars) are
displayed. Limit of detection = 17 cfu per sample. Statistical significance of difference
between ANB titers was determined by unpaired t-test (log 10 -transformed titers).
Representative of ≥2 independent experiments per group.
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Figure 3.21: Representative Bacteroides colonies and fecal titer plate.
(A) Pure cultures of (1.) B. vulgatus, (2.) Bacteroides sp. TP5, and (3.) B.
thetaiotaomicron isolates streaked on BBE media and incubated anaerobically for 48 hrs.
Insets: representative colonies of each isolate exhibiting characteristic size, morphology,
and pigmentation (scale bar = 1 mm). The culture plate was photographed with a digital
camera, and magnified images of representative colonies of each isolate (indicated by
black squares in the low-power image) were photographed on a dissecting microscope at
12.5X magnification images with both backlighting and reflected lighting at an exposure
time of 1/500 s.
(B) Representative BBE fecal titer plate from a B. thetaiotaomicron-gavaged mouse
exhibiting characteristic B. thetaiotaomicron colony appearance (imaged after 72-hr
anaerobic incubation). Bacterial identity confirmed as B. thetaiotaomicron by 16S rRNA
gene sequencing of representative colonies. Titer plates from mice gavaged with B.
vulgatus and Bacteroides sp. TP5 also exhibited colonies with the respective
characteristic morphology (not shown).

117

Figure 3.21

118

Figure 3.22: Gavaged Bacteroides stably colonize antibiotic-pre-treated mice at high
levels regardless of host genotype.
Serial fecal titers on BBE agar from antibiotic-pre-treated mice gavaged on Day 0 with
the indicated inoculum.
(A) Antibiotic-pre-treated mice of the indicated genotypes gavaged with sterile PBS or a
pure culture of B. thetaiotaomicron (6.6x107 cfu/mouse). Individual titers (symbols) and
means of log 10 -transformed titers (lines) are displayed. Statistical significance of
differences between log 10 -transformed fecal titers from B. thetaiotaomicron-gavaged
dnKO mice and Il10r2+/- mice determined by unpaired t-test.
(B) Antibiotic-pre-treated dnKO mice gavaged with a pure culture of Bacteroides sp. TP5
(8.9x107 cfu/mouse).
(C) Antibiotic-pre-treated dnKO mice gavaged with a pure culture of Bacteroides
vulgatus (9.1x107 cfu/mouse).
(D) Bacteroides titers from (A-C) overlaid. Representative of ≥2 independent
experiments with 2-6 mice per group for B. thetaiotaomicron and Bacteroides sp TP5;
Not repeated for B. vulgatus at this gavage dose, but mice gavaged with a 10-fold higher
dose became colonized at similar levels.
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Figure 3.23: Bacteroides colonization of gavaged, antibiotic-pre-treated mice is high,
consistent, and normally distributed.
Frequency histogram of all 92 B. thetaiotaomicron fecal titer measurements that we have
performed on gavaged, antibiotic-pre-treated mice regardless of mouse genotype. Fecal
titers were performed 6, 13, or 20 days post-gavage and are compiled from multiple
independent experiments with 4-9 mice per experiment. Gavage doses ranged from
6.6x107 to 8.6x108 cfu/mouse. After exclusion of the outlier value of 8.78, the data are
normally distributed as determined by the D'Agostino & Pearson K2 omnibus normality
test: p = 0.5894, K2 = 1.057, skewness = -0.153, kurtosis = 0.3345. Analysis performed
using GraphPad Prism version 5.01 for Windows (GraphPad Software) because the test is
not available in Prism v3.02.
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Figure 3.24: Commensal Enterobacteriaceae but not commensal Bacteroides are
strikingly enriched in spontaneous colitis.
(A to C) Fecal samples from 4 week old untreated mice of the indicated genotypes or
mice treated with antibiotics for ≥3 weeks titered in parallel anaerobically on ANB and
BBE agar and aerobically on MacConkey agar (selective for Enterobacteriaceae).
Il10r2+/- and dnKO mice were co-housed; data compiled from ≥2 cages/group. Statistical
significance determined by 1-way ANOVA (ANB titers: F 3,13 = 1.344, p = 0.3031) or
unpaired t-test (log 10 -transformed titers).
(D) Approximate percentages of BBE- and MacConkey-cultivable fecal bacteria in
untreated Il10r2+/- and dnKO mice from (A) to (C) calculated by dividing BBE titers and
MacConkey titers of by the corresponding titers of total cultivable bacteria (on nonselective ANB agar). Percentages of "Other" were calculated by subtracting BBE and
MacConkey percentages from 100%. Genotypes and housing arrangements of the mice
are shown.
(E and F) Proportions of total cultivable bacteria from (D) displayed using a logarithmic
scale. Displayed as individual (symbols) and means of log 10 -transformed proportions
(bars). Unpaired t-test (log 10 -transformed proportions).
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Figure 3.24
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Figure 3.25: Isolation of Escherichia coli from the feces of an untreated dnKO
mouse.
A prominent, distinctive bacterial colony type (convex, circular, white-yellow, entire
margins, strongly β-hemolytic, 2-3 mm diameter after 48 hrs incubation) was isolated
from the feces of an untreated (spontaneously colitic) dnKO mouse cultured on ANB
agar. The colony type comprised 33% of all colonies observed on the titer plate (2.0x109
cfu/g out of 6.0x109 total cfu/g).
(A) The isolate was identified by as Escherichia coli, a member of the family
Enterobacteriaceae, by 16S rRNA sequence identity to the closest cultured isolate,
supplemented by phenotypic identification (phenotyping performed by W. M. Dunne, Jr.;
in the Barnes-Jewish Hospital Medical Microbiology Laboratory. Table lists isolate ID,
most similar bacterial type strain, percent sequence identity, and accession number of
type strain sequence.
(B) H&E stained histology of the descending colon of the untreated dnKO mouse from
which E. coli was isolated and of a co-housed untreated Il10r2+/- mouse. Scale bar = 200
µm.
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Figure 3.25
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Figure 3.26: E. coli stably colonizes gavaged, antibiotic-pre-treated mice.
Serial fecal titers cultured in parallel on BBE and MacConkey agar from antibiotic-pretreated dnKO mice (5-6 per group) gavaged with sterile PBS, B. thetaiotaomicron (1x108
cfu/mouse), or Escherichia coli (2x108 cfu/mouse). Bacterial identity was determined by
colony characteristics, confirmed by sequencing the 16S rRNA gene of representative
colonies. Representative of ≥2 experiments per group.
(A) B. thetaiotaomicron colonization (BBE agar).
(B) E. coli colonization (MacConkey agar).
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Figure 3.26
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Figure 3.27: E. coli does not induce significant gross pathology in antibiotic-pretreated dnKO mice.
Pathology scores of intestines from mice described in Figure 3.26 displayed as individual
(symbols) and median (bars) scores. Statistical significance determined by KruskallWallis test with post-hoc Dunn's test. All significant pairwise comparisons are displayed:
*, p < 0.05; **, p < 0.01. Representative of ≥2 experiments per group.
(A) Cecum pathology scores: H 2 = 11.49, p = 0.0032.
(B) Transverse colon pathology scores: H 2 = 12.02, p = 0.0025.
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Figure 3.27
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Figure 3.28: E. coli does not induce significant histologic colitis in antibiotic-pretreated dnKO mice.
Quantitative histologic disease metrics of intestines from mice described in Figure 3.26
displayed as mean +/- SEM. Statistical significance determined by 1-way ANOVA with
post-hoc Tukey's test. All significant pairwise comparisons are displayed if omnibus pvalue by ANOVA was significant: *, p < 0.05.
(A) Transverse colon crypt height: F 2,14 = 2.580, p = 0.1112.
(B) Transverse colon crypt width: F 2,14 = 5.434; p = 0.0179.
(C) Rectum crypt height: F 2,14 = 6.438, p = 0.0104.
(D) Rectum crypt height: F 2,14 = 7.268, p = 0.0068.
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Figure 3.28
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Figure 3.29: Schematic summary of findings.
dnKO mice (genetically susceptible to IBD) develop spontaneous colitis characterized by
enrichment of commensal Enterobacteriaceae in the intestinal microbiota compared to
Il10r2+/- (non-susceptible) mice, which do not develop disease. Antibiotic treatment
prevents disease and eliminates both commensal Bacteroides and commensal
Enterobacteriaceae from the microbiota. After cessation of treatment, mice remain
healthy and free of Bacteroides and Enterobacteriaceae. Antibiotic-pre-treated mice
experimentally colonized with individual isolates of Bacteroides or Enterobacteriaceae
become robustly colonized independent of host genotype, but disease develops only in
IBD-susceptible hosts colonized with Bacteroides.
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Figure 3.29
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Table 3.1: Preparation of a standardized, frozen stock of intestinal contents.
Intestinal contents from untreated, non-dnKO mice were suspended in sterile, prereduced PBS in an anaerobic chamber and frozen in single-use aliquots in 20% glycerol
at -80°C. Prior to freezing, an aliquot of the mixture was titered on the indicated media
types. Subsequently, freshly thawed aliquots were adjusted to the same concentration of
total intestinal contents and titered on the same media types.

Growth
Conditions

Media
Type

Colony Type

Pre-freeze
mixture (no
glycerol)
CFU/mL

Anaerobic

ANB

Aerobic

Chocolate

4.20E+08
1.41E+05
4.70E+06

Total
β-hemolytic
Total
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Post-freeze
mixture adjusted
to same dilution
(some residual
glycerol)
CFU/mL

% Loss in
viability due to
freezing

7.00E+07
1.20E+05
2.32E+06

16.7%
85.1%
49.4%

Table 3.2: Preparation of bacterial mixed cultures of intestinal contents to screen
for colitis induction.
Serial 100.5-fold dilutions of intestinal contents (see Methods) were plated in parallel on
solid media and incubated either anaerobically or aerobically on a variety media types
(see Figure 3.12). Cultures was harvested from plates at the indicated dilutions and frozen
at -80˚C in single-use aliquots with 20% pre-reduced glycerol. The table lists culture
conditions, media types, 10-fold dilution factors, and numbers of cfu on the plates from
which cultured bacteria were harvested.

Culture
Conditions

10-Fold Dilution Factor of
Intestinal Contents from
Untreated Mice

# of Colonies
on Source
Culture Plates

ANB
ANB
CNA
LKV

Anaerobic

1
4.5
4.5
4

~6.3 x 106
~1.4 x 103
~1.6 x 103
~1.4 x 103

Chocolate

Aerobic

0

~3.9 x 105

Media
Type
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Table 3.3: Unique bacterial isolates from LKV media.
Unique species of commensal bacteria isolated from the intestinal microbiota of untreated
mice using LKV agar. Isolates were identified by 16S rRNA gene sequence analysis
using the Ribosomal Database Project supplemented by BLAST. Sequence identity to
bacterial type strains and closest cultured isolates was determined by BLAST2 analysis.
All were >99% identical to sequences detected in metagenomic sequencing of rodent
commensal microbiota (not shown).
Isolate ID

Closest Type Strain
(Closest Cultured Isolate)

% Identity

dnLKV2

Bacteroides uniformis

99%

dnLKV3

Bacteroides massiliensis
(Bacteroides sp. TP-5)

94%
(99%)

dnLKV6

Lactobacillus animalis
(Lactobacillus murinus, ASF 361)

99%
(99%)

dnLKV7

Bacteroides dorei
(Bacteroides vulgatus)

97%
(99%)

dnLKV8

Parabacteroides distasonis

97%

dnLKV9

Bacteroides thetaiotaomicron

99%

dnLKV18

Parabacteroides goldsteinii
(Bacteroides sp. ASF519)

99%
(99%)

dnLKV27

Parasutterella excrementihominis,
gen. nov., sp. nov.

96%

dnLKV22

Parasutterella excrementihominis,
gen. nov., sp. nov.

93%
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CHAPTER 4
Future directions
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Introduction

A large number of interesting and important future directions arise from this
work. I will focus primarily on those related to determining if there is molecular basis for
the specificity of disease induction by Bacteroides species and determining whether and
how this microbial specificity is related to host-genotype-specific interactions with T
cells, since I believe this to be most relevant to the Stappenbeck-Allen lab collaboration.
However I will first briefly mention two other potential future directions.

Brief Future Direction 1: dnKO mice as a potential model of quiescent colitis and
IBD-associated colon carcinogenesis
Metronidazole and ciprofloxacin resulted in rescue of severely diseased mice
within a matter of weeks (see Chapter 2), establishing a system that could serve as a
straightforward and relevant model for studying the epithelial events that characterize
quiescent IBD. Importantly, IBD colitis has significant association with colon cancer
(Greenstein, Sachar et al. 1979), and the mechanisms by which IBD-associated cancers
develop differ in important aspects from sporadic colon cancer (Itzkowitz 2003). We
suggest that dnKO mice could be useful as a model for examining the progression from
colitis to cancer and how it is influenced by inflammatory processes. Importantly, these
experiments can be performed without relying on chemical agents to induce
inflammation. At present we have only examined a small number of mice with quiescent
colitis, and further work will be needed to determine whether they spontaneously show
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signs of dysplasia and carcinogenesis. As a cautionary note: one obvious approach would
be to cycle mice on and off of antibiotics, co-housing them with an untreated mouse after
each round of treatment. Although an attractive option, care would be required to monitor
and prevent the development and spread within the mouse colony of antibiotic-resistant
(particularly ciprofloxacin-resistant) bacteria.

Brief Future Direction 2: Isolation of rare or novel intestinal anaerobes
The bacteriology cultivation methods described here resulted in isolation of a
number of species of Firmicutes, Bacteroidetes, and Proteobacteria that appeared, based
on 16S rRNA sequence analysis, to represent novel species and possibly even novel
genera that have previously been detected solely in culture-independent mass sequence
analysis of the intestinal microbiota. A number of these isolates did not survive during
my initial, large-scale, un-targeted attempts at mass isolation. However a more focused
approach would undoubtedly lead to better success in maintaining viability of even
extremely fastidious and hard-to-grow bacteria. In particular, I note a number of
important and promising candidates or candidate approaches.
1.) Bacteroides sp. TP5 (isolate dnLKV3, see Chapter 3) may be a novel species and
is viable and easily grown on the culture media described here. Further
phenotypic workup could result in confirming and publishing it as a novel
species.
2.) We isolated two different Betaproteobacteria related to Parasutterella
excrementihominis gen. nov., sp. nov. (Nagai, Morotomi et al. 2009). Each of
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these isolates may have represented a novel species. They were extremely slow to
grow and not highly abundant in the microbiota, forming very small, slowgrowing colonies on BBE, LKV, or ANB agar. However they were isolatable on
these selective media types and I see no reason why they or closely related
Betaproteobacteria could not be isolated again by similar methods.
3.) I have succeeded in isolating a number of bacteria that appear to fall within understudied

families

of

Firmicutes,

including

Lachnospiraceae

(which

are

Clostridiales) and Erisypelotrichaceae on anaerobic CNA agar. These organisms
have been more difficult to grown in culture and some of the isolates have lost
viability. However I have at least one isolate from each family that is still viable
in a frozen stock and is on the verge of 16S rRNA cutoff (97% identity) for being
a novel species (previously only detected by sequencing). Furthermore, our
laboratory recently reported on the fact that Lachnospiraceae are preferentially
enriched in the space between the transverse folds found in the mouse ascending
colon (Nava, Friedrichsen et al. 2010). It would be relatively straightforward to
sacrifice mice, immediately transfer their unopened colons into the anaerobic
chamber, open the colons, use a small probe to scoop out the material from
between the ascending colon folds, make dilutions, and plate it on anaerobic CNA
agar or another even more selective medium.
4.) A variety of papers have reported that treating mice with antibiotics targeting
subsets of bacteria can result in enrichment of other bacterial subsets within the
microbiota that presumably expand to fill the niches left vacant by the death of the

141

antibiotic-sensitive organisms (Rakoff-Nahoum, Paglino et al. 2004).

I have

made similar observations. Treating mice with different antibiotics and then
isolating bacteria that remain within the microbiota could potentially allow easier
access to bacteria which are normally of too low abundance for isolation. I
suggest treating for over a week before performing isolations, since the
microbiota will likely take some time to normalize from the effects of antibiotics
to achieve new stable microbial communities.

Major Future Direction: Mechanism of Bacteroides disease induction in dnKO mice.
The identification of specific disease-inducing and non-disease-inducing
commensal bacteria in the dnKO mouse model presents an exciting opportunity probe the
mechanisms of host-microbe interaction from both host and microbial perspectives. We
have now developed a number of useful immunologic and bacteriologic tools that enable
us to interrogate the underlying nature of commensal-induced immunopathology in this
model. As described in Chapter 3, we have shown specificity of Bacteroides species as
compared to at least a subset of other bacteria in inducing host-genotype-specific disease.
It remains an open question why this specificity was observed: is it because of one or
more specific Bacteroides-produced molecular factors, or is it attributable to differences
in bacterial “behavior” within the intestines?
On the host side, several pieces of evidence implicate T cells in the pathogenesis
of dnKO disease. The dnTfgβrii transgene in dnKO mice is expressed specifically in the
T cell compartment (Gorelik and Flavell 2000; Kang, Bloom et al. 2008). Previous data
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from our groups demonstrates that CD4 T cells from dnKO donors have substantially
stronger colitis-inducing effect than wild-type T cells when adoptively transferred into
Rag-/- recipients (Kang, Bloom et al. 2008). Similarly, we and others have shown that
transfer of Il10r2-/- T cells also induces more severe disease than wild-type T cells (Kang,
Bloom et al. 2008; Murai, Turovskaya et al. 2009). However it remains to be formally
determined whether the host-genotype-specific, Bacteroides-induced disease is
specifically attributable to T cells of the dnKO genotype or whether it also requires other
cell types. Assuming that a host-genotype-specific, bacterial-species-specific T-cellbacteria interaction is sufficient for disease, it will be important to understand what
effects the bacterial stimulus is inducing in the T-cells. Do the T cells simply exhibit
higher rates of activation, do they aberrantly differentiate to adopt a pathologic phenotype
(e.g. Th1 vs. Th2), or is there a failure to develop or respond to regulatory T cells in the
context of the colon?
Even if we confirm that disease is due a specific combination of Bacteroidesspecific microbial stimulation and host-genotype-specific T cells, it will be important to
determine whether the resulting immunopathology depends on development of T cell
receptors (TCRs) directed against specific Bacteroides-produced antigens or whether
Bacteroides-produced factors somehow induce more generalized host-genotype-specific
T cell activation that can lead to reactivity against any potential antigen. I am personally
inclined to favor the second option. I am aware of no reason why the genetic signaling
defects present in dnKO mice as compared to Il10r2+/- mice would cause them to develop
fundamentally different TCR repertoires in naïve T cells that could account for the host-
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genotype-specific nature of the response to identical bacterial stimuli. Thus, although
many dnKO T cells presumably do react against bacterial antigens during disease and
some of the antigens in question may be produced by bacteria that play a direct role in
disease induction, I suspect that it will be more important to determine why the T-cells
have been stimulated to react pathologically rather than to identify what they are reacting
against.
There is intriguing published evidence supporting the idea that Bacteroides
species produce molecules which could cause aberrant host-genotype-specific immune
responses in a non-antigen-dependent fashion. Bacteroides fragilis produces a
zwitterionic capsular polysaccharide molecule (PSA) that in wild-type mice promotes
Th1 skew but also promotes mucosal tolerance in the colon by triggering development of
inducible Foxp3+ regulatory T cells (Mazmanian, Liu et al. 2005; Mazmanian, Round et
al. 2008; Round and Mazmanian 2010; Strober 2010). Regulatory T cell induction
appears to require stimulation of naïve T cells by IL-10 produced in a TLR2-dependent
fashion, likely by antigen-presenting cells and/or the T-cells themselves (Mazmanian,
Round et al. 2008; Round and Mazmanian 2010). In the absence of IL-10 production or
blockade of the IL-10 receptor, the PSA molecule failed to induce tolerance and may
even have been paradoxically pro-inflammatory (Mazmanian, Round et al. 2008; Strober
2010). Intriguingly, there are suggestions from genomic data that many other intestinal
Bacteroidales species may make similar zwitterionic polysaccharides, with the
implication that these molecules might also modulate T cell differentiation in IL-10
dependent fashion (Comstock 2009). Thus, the effects of Bacteroides in dnKO mice may
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have a molecular cause that is independent of a particular T cell antigen or TCR
specificity.

Hypothesis: A molecular factor specifically present in commensal intestinal Bacteroides
species(Aim 1) induces host-genotype-specific immunopathologic T-cell activation and/or
altered differentiation(Aim

2)

in a process that is not dependent on a specific bacterial

antigen.(Aim 3)

Specific Aims:
1.) Assay for the presence of molecules that are present specifically in Bacteroides
species but not in non-colitogens (e.g. E. coli and the residual bacteria in
antibiotic-treated mice) which have pro-colitic or pro-inflammatory activity in
dnKO but not in Il10r2+/- mice.
a. Treat dnKO and Il10r2+/- mice currently receiving antibiotic therapy with
lysates of colitis-inducing and non-colitis-inducing bacteria in drinking
water to assess whether host-genotype-specific, Bacteroides-specific
disease-induction occurs.
i. If so, consider biochemically fractionating the lysate.
b. Perform intraperitoneal and/or foot-pad injections of dnKO and Il10r2+/mice currently receiving antibiotic therapy using lysates of colitisinducing and non-colitis-inducing bacteria and assess whether a hostgenotype-specific, Bacteroides-specific hyperactive immune response
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occurs in the injected region, draining lymph node, or spleen (as
appropriate to the site of injection). Characterize the response.
c. Harvest naïve T-cells, preferably from antibiotic-treated, non-colitic dnKO
and Il10r2+/- mice, culture them with antigen-presenting cells, pulse with
bacterial

lysates,

and

assess

whether

a

host-genotype-specific,

Bacteroides-specific response occurs.
2.) Assess whether adoptively transferred T-cells from dnKO donors but not from
Il10r2+/- donors preferentially induce disease in Rag-/- mice colonized with
Bacteroides, but not in mice colonized with E. coli or mock-colonized.
a. Assess the phenotypes of the transferred cells in each case to determine if
there are differences in activation, polarization, or regulatory T cell
development.
b. Alternate approach: T cell deplete dnKO mice to determine whether
disease course is affected.
3.) Assess whether the adaptive immunes response in Bacteroides-colonized, colitic
dnKO mice is specifically targeted against particular Bacteroides molecules or
whether it is a more general phenomenon wherein Bacteroides-colonized dnKO
mice also develop pathological immune responses against normally noncolitogenic bacteria or antigens.
a. Assess whether pre-immunization with killed Bacteroides induces a more
strongly immunopathologic response upon colonization or re-challenge
(Onderdonk, Cisneros et al. 1983).
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b. Inject antigens that normally lack intrinsic colitis-inducing activity into
dnKO mice along with the killed Bacteroides and assess whether an
immune response targeting them develops.
i. Assess whether immune responses develop against bacteria that
were present at high levels in the intestinal tract of dnKO mice
prior to Bacteroides colonization (when the mice were non-colitic).
c. Perform in vitro assays to determine the percent of T cells reactive to the
introduced Bacteroides species as compared to other antigens from the gut
milieu.
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